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Abstract

Cancer among Asian American Population in the United States:
Incidence and Survival Disparities
by
Hongbin Jin

Dr. Paulo S. Pinheiro, Examination Committee Chair
Associate Professor of the Department of Environmental and Occupational Health
University of Nevada, Las Vegas

Part I

Cancer incidence disparities exist among specific Asian American populations. However, the
existing reports exclude data from large metropoles like Chicago, Houston, and New York.
Moreover, incidence rates by subgroup have been underestimated due to the exclusion of Asians
with unknown subgroup. Cancer incidence data for 2009 to 2011 for eight states accounting for
68% of the Asian American population were analyzed. Race for cases with unknown subgroup
was imputed using stratified proportion models by sex, age, cancer site, and geographic regions.
Age-standardized incidence rates were calculated for 17 cancer sites for the six largest Asian
subgroups. Our analysis comprised 90,709 Asian and 1,327,727 non-Hispanic white cancer cases.
Asian Americans had significantly lower overall cancer incidence rates than non-Hispanic whites
(336.5 per 100,000 and 541.9 for men, 299.6 and 449.3 for women, respectively). Among specific
Asian subgroups, Filipino men (377.4) and Japanese women (342.7) had the highest overall
incidence rates while South Asian men (297.7) and Korean women (275.9) had the lowest. In
comparison to non-Hispanic whites and other Asian subgroups, significantly higher risks were
iii

observed for colorectal cancer among Japanese, stomach cancer among Koreans, nasopharyngeal
cancer among Chinese, thyroid cancer among Filipinos, and liver cancer among Vietnamese. South
Asians had remarkably low lung cancer risk. Overall, Asian Americans have a lower cancer risk
than non-Hispanic whites, except for nasopharyngeal, liver and stomach cancers. The unique
portrayal of cancer incidence patterns among specific Asian subgroups in this study provides a
new baseline for future cancer surveillance research and health policy.

Part II
Globally, Asian countries bear a disproportionate gastric cancer burden. Asian Americans, the
fastest growing minority population in the US, show not only higher incidence of gastric cancer
compared to non-Hispanic whites (NHWs), but also significantly higher survival. Benefiting from
more uniform staging and treatment practices within the US, we examine for the first time the
heterogeneity in the Asian American population, which may elucidate the causes of these
disparities. SEER data from 2000 to 2012 were used to calculate 5-year survival estimates for
NHWs and the six largest Asian ethnicities. Multivariate analyses were performed to identify
critical prognostic factors and survival disparities between Asian groups and NHWs. We analyzed
33,313 NHW and 8,473 Asian gastric cancer cases. All Asian groups had significantly higher 5year survival than NHWs, at 29.8%. Among Asians, Koreans and Vietnamese had the highest and
lowest survival, 45.4% and 35.7%, respectively. The Korean survival advantage was largely
attributable to relatively high proportions of localized stage and low proportions of cardia tumors.
After adjusting for major prognostic factors, the survival disadvantage of NHWs, while attenuated,
remained significant in comparison to all Asian groups (HR: 1.33; 95% CI: 1.24-1.43; reference:
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Korean). The survival disparities within the Asian groups vanished with adjustment. This study
characterizes distinctive gastric cancer survival patterns among the six major Asian groups and
NHWs in the US. The causes of the survival disadvantage for NHWs remain elusive. The observed
survival disparity affecting NHW in relation to Asians points to the need for increased awareness
of gastric cancer screening and treatment options of NHWs, who account for the majority of cases.
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Chapter 1
Introduction
Cancer is the second leading cause of death in the United States (US), accounting for
approximately 23% of deaths in 2011 (CDC, 2012a). Although the death rate for cancer in the US
has been exhibiting a gradual but consistent descending trend since 1993 (CDC, 2010), many
population groups across the US suffer disproportionately from cancer and benefit less from cancer
control and prevention. In 2000, the Minority Health and Health Disparities Research and
Education Act defined health disparities as
“A population is a health disparity population if there is a significant disparity in
the overall rate of disease incidence, prevalence, morbidity, mortality or survival
rates in the population as compared to the health status of the general
population.” (United States Public Law 106-525, p. 2498)
With the promulgation of US Public Law 106-525, the National Cancer Institute (NCI) defines
cancer health disparities as “adverse differences in cancer incidence, cancer prevalence, cancer
death, cancer survivorship, and burden of cancer or related health conditions that exist among
specific population groups in the US” (NCI, 2008). A variety of factors have been researched to
characterize these underserved population groups. Among them, race/ethnicity is one of the most
widely accepted factors to understand cancer health disparities and becomes one of the criteria to
fund and shape public health intervention programs against cancer (National Academies of
Sciences, Engineering, and Medicine, 2002).
The Asian American population grew faster than any other racial/ethnic group in the US over
the last decade, representing 5.6% of the US population (US Census, 2012a). Oftentimes, they are
1

considered a model minority because of their remarkable economic and educational success as
well as social assimilation (Gomez et al., 2013). According to the 1999-2010 Cancer Report from
US Cancer Statistics (USCS, 2015), Asian and Pacific Islanders (APIs) have significantly lower
overall incidence and mortality than non-Hispanic whites, non-Hispanic blacks, and Hispanics.
Given the impression of model minority and superior overall cancer statistics, Asian Americans
are routinely considered to bear less burden of cancer than the general population. However, these
misleading stereotypes might obscure health disparities among Asian Americans and mask many
unmet public health needs including hampering battles against cancer.
The US Asian American population is comprised of numerous subgroups with different
geographic origins. The majority of Asian Americans in the US came from over 50 different
countries and speak over 100 different languages, of which 36.2% arrived in the US in 2000 or
later (US Census, 2012a). This immigrant-dominant population carries distinctive cancer profile
prevalent in Eastern countries, characterized by high prevalence in cancers of infectious origin,
such as stomach cancer, liver cancer, and cervical cancer (Miller, Chu, Hankey, & Ries, 2008;
Gomez et al., 2013). Also, with the assimilation into the US mainstream culture, their original
lifestyles are challenged by their western counterparts, resulting in increased risk of diseases of
civilization, such as breast cancer (Chia et al., 2005; Gomez et al., 2010).
By virtue of different cultural backgrounds, lifestyles, and immigration histories, cancer
incidence and survival among US Asian American population are dramatically heterogeneous
(Pineda, White, Kristal, & Taylor, 2001; Lin et al., 2002; Kwong, Chen, Snipes, Bal, & Wright,
2005; Chang et al., 2007; McCracken et al., 2007; Miller et al., 2008; Ou, Ziogas, & Zell, 2009;
Le, Ziogas, Taylor, Lipkin, & Zell, 2009; Goggins & Wong, 2009; Gomez, et al., 2010; Gomez et
al., 2013). However, cancer health disparities among specific Asian subgroups have been
2

infrequently studied mostly due to the complexity and difficulty in collecting data on race/ethnicity
by cancer registries (Nguyen, Chawla, Noone, & Srinivasan, 2014; Gomez et al., 2014) and lack
of comparably-detailed population estimates (McCracken et al., 2007; Miller et al., 2007). The
North American Association of Central Cancer Registries (NAACCR) has published guidelines
for collecting and coding race/ethnicity data, which allow recording detailed Asian subgroups. In
addition, new procedures, such as the NAACCR Asian and Pacific Islander Identification
Algorithm (NAPIIA), have been suggested to enhance the identification of detailed subgroups in
Asian Americans. However, a noteworthy fraction of cancer cases among US Asian Americans
have unknown detailed subgroup, with proportions that have been steadily rising over the last
decades. On the other hand, detailed and accurate population estimates for detailed Asian
subgroups are accessible only from the decennial US Census. As a result, national statistics on
cancer for specific Asian subgroups are not routinely available (McCracken et al., 2007).
Revealing cancer health disparities among Asian Americans requires accurate incidence and
survival estimates for each specific Asian subgroup. However, dominant cancer research literature
tends to aggregate Asian subgroups into one large group, which obscures the diversity and
complexity of Asian Americans. Of those examined descriptive epidemiology of cancer by specific
Asian subgroup (Deapen , Liu, Perkins, Bernstein, & Ross, 2002; Chang et al., 2007; McCracken
et al., 2007; Miller et al., 2008; Raz et al., 2008; Chang et al., 2009; Ou et al., 2009; Keegan et al.,
2010; Wang, Carreon, Gomez, & Devesa, 2010; Gomez et al., 2010; Horn-Ross et al., 2011; Clarke
et al., 2011; Liu, Zhang, Wu, Pike, & Deapen, 2012; Gomez et al., 2013), cancer data from the
Surveillance, Epidemiology, and End Results (SEER) Program were favored due to its reputation
for validity and convenience. However, SEER only covers up to approximately 50% of US Asian
American and 65.8% of them reside in California (US Census, 2012a). Therefore, using SEER's
3

population bases solely may not be able to provide a robust assessment on cancer health disparities
in Asian Americans. Besides, to the author’s knowledge, no previous research study has taken
Asian Americans with unknown detailed group into account. Statistical exclusion is the most
common technique to treat such group due to lack of methods to effectively utilize categorical data
with missing values. Yet, with the rapidly rising proportion of this group in cancer registry data,
incidence rates for each detailed Asian subgroup are underestimated with varying magnitude.
Moreover, US Census allows respondents to report more than one race since 2000, resulting in 4
different population estimates for each Asian subgroup (US Census, 2012a). This new feature
facilitates research on multiracial populations while complicates computation of population
denominators. Averaging groups with one race and multiple races will result in inflated population
estimates and underestimated incidence rates.
Numerous studies have showed racial differences in deaths from cancer among non-Hispanic
whites and Asian Americans (Wong et al., 1999; Pineda et al., 2001; Trinh et al., 2015). Racial
disparities in cancer survival outcomes have been primarily attributed to underlying biologic
mechanisms and the quality of cancer care received (Trinh et al., 2015). Among Asian subgroups,
the uneven distribution of socioeconomic status (SES) and inequalities of care may also cause
cancer survival disparities among specific Asian subgroups. Stomach cancer is the fifth most
common cancer and the third leading cause of cancer death worldwide (International Agency for
Research on Cancer, 2016). In the US, stomach cancer disproportionately affects Asian Americans
(Gomez et al., 2013). However, very few literature has investigated the stomach survival difference
among Asian subgroups in the US.
Overcoming cancer health disparities is one of the keystones to unload the burden of cancer in
the US Investigation of cancer health disparities among detailed Asian subgroups is critical to
4

identify underserved populations and translate epidemiological knowledge into effective targeted
cancer control programs. The goal of the present study is to investigate cancer incidence and
stomach cancer survival disparities among major Asian subgroups (Chinese, Filipino, Japanese,
Korean, South Asian, and Vietnamese) in the US.
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Chapter 2
Background
Cancer
Cancer is one of the leading causes of death globally (World Health Organization, 2015). In
2012, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people
living with cancer (diagnosed within 5 years) worldwide. The World Health Organization (WHO)
estimated that the annual incident cases will rise to 22 million within the next two decades if action
is not taken (IARC, 2012). Similar to other developed countries, the United States (US) has higher
cancer incidence but lower death rate compared to global average (WHO, 2015). Despite relatively
sufficient resources for cancer prevention, diagnosis and treatment, cancer remains the second
leading cause of death in the US (CDC, 2013) and is expected to cause approximately 1.7 million
incident cases and 0.6 million deaths in 2016 (American Cancer Society, 2016).
Although the causes of cancer are still unclear, but cancer research has indicated that they are
a combination of genetic factors, lifestyle factors, certain types of infections, and environmental
exposures (American Cancer Society, 2016). Previous research studies have shown that only 510% of all cancer cases are attributable to genetic defects, whereas the remaining 90-95% are
caused by interaction with environment (Figure 1) (Mucci, Wedren, Tamimi, Trichopoulos, &
Adami, 2001; Czene & Hemminki, 2002; Anand et al., 2008). The major known environmental
factors include tobacco use, diet, infection, obesity or physical inactivity, alcohol use, certain
chemicals, and radiation. These findings form the basis of contemporary cancer prevention and
control and ascertain that cancer is largely preventable (Anand et al., 2008).
Tobacco
6

Smoking, as well as secondhand smoke, has been linked to increased risk for many kinds of
cancer, such as lung cancer, head and neck cancer, bladder cancer, kidney cancer, leukemia, and
breast cancer (WHO, 2004a). Lung cancer is the leading cause of cancer death and the second most
common cancer in the US for both men and women (American Cancer Society, 2016). Not
smoking or quitting smoking lowers the risk of getting cancer and dying from cancer. Smoking
rates differ significantly by race in the US (CDC, 2014a). According to the US National Health
Interview Survey 2005-2014, Asian adults had the lowest prevalence of current cigarette smokers
(9.5%) compared with the national average (16.8%) in 2014. The smoking rates among detailed
Asian subgroups have not been updated lately, but findings from the National Survey on Drug Use
and Health, 2002-2005 showed that tobacco product use varied significantly among detailed Asian
subgroups (Table 1). Vietnamese and Koreans had higher frequency of using tobacco products
than other Asian subgroups (Caraballo, Yee, Gfroerer, & Mirza, 2008).

Figure 1. The role of genes and environment in the development of cancer
Source: Cancer is a preventable disease that requires major lifestyle changes, Anand et al., 2008)
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Table 1. Percent of respondents aged 18 or older who used tobacco products during the past 30 days, 2002–2005
Population

Tobacco Use Rate (%)

95% CI

Non-Hispanic white

33.0

32.6-33.5

Total Asian

15.8

14.3-17.3

Chinese

10.0

7.8-12.8

Filipino

17.0

13.9-20.5

Asian Indian

12.8

10.0-16.4

Vietnamese

22.5

17.3-28.7

Korean

28.4

22.9-34.6

Japanese

15.2

11.5-19.9

Source: Adult tobacco use among racial and ethnic groups living in the United States, 2002-2005, Caraballo et al., 2008

Diet
The effects of diet on cancer risk vary drastically by cancer site (Willett, 2000). For example,
up to 70% of colorectal cancer, the third most common cancer among men and women in the US,
can be attributed to diet. Heavy consumption of fat, a characteristic of typical Western diet, has
been linked to gastrointestinal cancer (Haggar & Boushey, 2009). Excessive fat benefits the
growth of a bacterial flora capable of degrading bile salts into potentially carcinogenic N-nitroso
compounds (NOCs). Endogenous NOC formation can be promoted by heme iron in red meat and
inhibited by vitamin C in fruit and vegetables (Dubrow et al., 2010).
Traditional Asian diet, characterized by predominantly rice and whole grains, abundant fruits
and vegetables, and moderate meat and fish consumption, is considered to be healthy and cancerpreventing. A variety of common ingredients in Asian cuisine, such as isoflavone in soybean,
catechin in tea, and curcumin in curry, have demonstrated protective effects against cancer in many
epidemiological studies (Yamamoto, Sobue, Kobayashi, Sasaki, & Tsugane, 2003; Basnet &
Skalko-Basnet, 2011; Yuan, 2013). However, certain diet habits in Asians, such as favoring
fermented foods high in salt and NOCs and raw seafood, may also increase the risk for
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gastrointestinal cancer and cancers of infectious origin (Ananthakrishnan, Gogineni, & Saeian,
2006; Shin, Kim, & Park, 2011)
Infection
Certain viruses and bacteria can cause cancer directly or indirectly (NCI, 2015). For example,
Human papillomavirus (HPV) is well known for causing cervical cancer, as well as cancers in
penis, vagina, anus, and oropharynx (Lowy & Schiller, 2012). Hepatitis B (HBV) and hepatitis C
viruses (HCV) can cause cirrhosis and increase the risk for liver cancer (Nguyen & Keeffe, 2003).
Helicobacter pylori increases the risk for stomach cancer (World Gastroenterology Organization,
2010). Worldwide, nearly 17.8% of cancer is associated with infectious diseases (Anand et al.,
2008). Despite the presence of effective vaccines (HBV and HPV), screening (mammogram, pap
smear and gastroscopy) and diagnostic tools (urea breathe test for H. Pylori and DNA test for
HPV), US Asian Americans are disproportionately affected by infection-related cancers,
particularly cancers of the cervix, stomach, liver, and nasopharynx (McCracken et al., 2007),
which is primarily ascribed to foreign-born Asians who acquired infections in their countries of
origin.
Obesity
Obesity has been associated with higher risk of colorectal cancer, postmenopausal breast
cancer, endometrial cancer, kidney cancer, esophageal cancer, and pancreatic cancer (NCI, 2015).
A national perspective cohort study in the US demonstrated that 14% of all cancer deaths in men
of 50 years of age or older and 20% in women of 50 years of age or older can be attributed to
overweight or obesity (Calle, Rodriguez, Walker-Thurmond, & Thun, 2003). Generally, Asian
Americans are considered carrying less burden of obesity due to their healthier lifestyles.
9

According to the Summary Health Statistics for US Adults, 2011 (CDC, 2012b), Asian Americans
of 18 years of age and over were 12% and 65% less likely to be overweight and obese than nonHispanic whites, respectively. However, rates of overweight and obesity vary greatly among
detailed Asian subgroups (Table 2). Filipinos and Asian Indians had higher overweight rates than
the other Asian subgroups, which were similar to non-Hispanic whites (CDC, 2008). Filipinos also
had higher obesity rate than the other Asian subgroups.
Table 2. Age-adjusted percent distributions of overweight and obese for Asian American of 18 years of age and over, 2004–2006
Population

Overweight (%)

Obese (%)

Non-Hispanic white

34.6%

23.6%

Total Asian

27.5%

8.1%

Chinese

21.8%

4.2%

Filipino

33.0%

14.1%

Asian Indian

34.4%

6.0%

Vietnamese

19.1%

5.3%

Korean

27.3%

2.8%

Japanese

25.9%

8.7%

Source: Health Characteristics of the Asian Adult Population: United States, 2004-2006. CDC, 2008

Alcohol
Studies have revealed that chronic moderate or heavy alcohol consumption is a risk factor for
oral cancer, esophageal cancer, breast cancer, colorectal cancer, and liver cancer (NCI, 2015). In
the respiratory tract and the upper digestive tract, 25-68% of cancers are attributable to alcohol (La
Vecchia, Tavani, Franceschi, Levi, Corrao, & Negri, 1997). Smoking and alcohol together have a
synergistic effect on cancer risk (Pelucchi, Gallus, Garavello, Bosetti, & La Vecchia, 2006). Up to
80% of cancers in the respiratory tract and the upper digestive tract can be prevented by abstaining
from smoking and alcohol (La Vecchia et al., 1997). According to the results from the 2010
National Survey on Drug Use and Health (US Department of Health and Human Services, 2011),
Asian Americans had lower current alcohol use and lowest binge and heavy alcohol use. Alcohol
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use among detailed Asian subgroups are strongly affected by ethnic drinking cultures and
conditioned by the degree of integration into the ethnic cultures (Cook, Mulia, & Karriker-Jaffe,
2012). Among the major six Asian subgroups, Asian Indians and Vietnamese consumed the
smallest volume of alcohol, followed by Filipinos and Chinese. Koreans consumed the largest
volume of alcohol, followed by Japanese (WHO, 2004b).
Other
Environmental pollution has been linked to various cancers (Anand et al., 2008). Exposure to
indoor and/or outdoor air pollutants and carcinogen-contaminated foods can increase the risk for
lung cancer, leukemia, lymphoma, colorectal cancer, etc. Radiation is another important risk factor
for cancer, particularly for skin cancer and melanoma. These risk factors are associated with living
and working conditions (mostly predicted by SES), which also vary among detailed Asian
subgroups (Pew Research Center, 2013)
Cancer is a largely preventable disease. Thanks to continued advances in cancer detection and
treatment as well as remarkable public health initiatives, cancer incidence and death rates in the
US continue to go down (Jemal et al., 2008; Edward et al., 2013; Kohler et al. 2015). According
to the Annual Report to the Nation on the Status of Cancer, 1975-2010, from 2001 through 2010,
the incidence rates decreased by averagely 0.6% per year among men and remained the same for
women, while death rates decreased by averagely 1.8% per year among men and 1.4% per year
among women (Edward et al., 2013). However, not all Americans are benefiting equally (CDC,
2014b), which necessitates further research on cancer incidence and survival disparities to identify
populations who are disproportionately affected by cancer.
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US Asian Americans
According to the US Office of Management and Budget, Asian American is defined as a person
having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian
subcontinent (US Census, 2012a). In 2010, Asian Americans accounted for 5.6% (17.3 million) of
the total US population and constituted the fastest growing racial/ethnic group in the US.
The US Asian American population is comprised of many detailed Asian subgroups
originating from over 50 different countries (Pew Research Center, 2013). Currently, in the US,
the six largest Asian subgroups are Chinese, Filipino, Asian Indian, Vietnamese, Korean, and
Japanese, altogether composed 88.7% of Asian Americans in 2010 (Table 3).
Table 3. The 20 largest US Asian subgroups by origin, 2010*
Rank

Asian subgroup

Population

Percentage

1

Chinese**

4,010,114

23.15%

2

Filipino

3,416,840

19.73%

3

Asian Indian

3,183,063

18.38%

4

Vietnamese

1,737,433

10.03%

5

Korean

1,706,822

9.85%

6

Japanese

1,304,286

7.53%

7

Pakistani

409,163

2.36%

8

Cambodian

276,667

1.60%

9

Hmong

260,073

1.50%

10

Thai

237,583

1.37%

11

Laotian

232,130

1.34%

12

Bangladeshi

147,300

0.85%

13

Burmese

100,200

0.58%

14

Indonesian

95,270

0.55%

15

Nepalese

59,490

0.34%

16

Sri Lankan

45,381

0.26%

17

Malaysian

26,179

0.15%

18

Bhutanese

19,439

0.11%

19

Mongolian

18,344

0.11%

20

Okinawan

11,326

0.07%

Total

17,320,856

* All Asians include mixed-race and mixed-group populations, regardless of
Hispanic origin. There is some overlap among groups
** Includes 215,441 Taiwanese
Source: The Asian Population: 2010, US Census Bureau
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Each Asian subgroup is distinctively heterogeneous because of its unique cultural background,
language, religious belief, economic and demographic trait, social and political value, and
immigration history. These attributes either inherited from country of origin or acquired in the US
profoundly shape Asian immigrants’ lifestyles and alter their risks for cancer. Many interrelated
factors contribute to the health disparities in cancer incidence and survival. A close look at these
factors is essential to understand cancer health disparities among US Asian Americans.
Nativity
The US is a nation of immigrants. Following the adoption of the Immigration and Nationality
Act of 1965, immigration has been a major source of population growth. According to the Census
(Figure 2), Asians accounted for 28% of the total foreign-born population in the US in 2010.

Figure 2. Change in foreign-born population by region of birth

In 2010, 74.1% of US Asian Americans were foreign-born and 28.8% of them immigrated
within the past decade (Table 4) (Pew Research Center, 2013). The rates of foreign-born were
relatively consistent across detailed Asian subgroups with only one exception of Japanese in 2010.
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Table 4. Characteristics of US Asian adults by origin, 2010* % (unless otherwise noted)
US
Total

Asian
Total

Chinese

Filipino

Indian

Vietnamese

Korean

Japanese

15.8

74.1

76.2

69.1

87.2

83.7

78.5

31.8

26.3

28.8

29.3

24.5

37.6

18.7

24.3

34.1

Median age (in years)

45.0

41.0

43.0

43.0

37.0

41.0

40.0

47.0

Married

51.4

59.0

59.2

56.3

70.9

57.0

55.7

52.7

Less than high school

14.4

13.9

18.0

7.7

9.2

29.7

7.7

4.8

High school or more

85.6

86.1

82.0

92.3

90.8

70.3

92.3

95.2

Bachelor’s degree or more

28.2

49.0

51.1

47.0

70.0

25.8

52.6

46.1

$40,000

$48,000

$50,000

$43,000

$65,000

$35,000

$45,000

$54,000

$49,800

$66,000

$65,050

$75,000

$88,000

$53,400

$50,000

$65,390

2.6

3.1

2.9

3.4

3.1

3.6

2.6

2.4

12.8

11.9

13.7

6.2

9.0

14.7

15.1

8.3

90.4

63.5

51.9

77.7

76.2

40.5

54.0

81.8

Northeast

18.3

20.1

27.4

9.7

31.1

10.1

21.3

8.6

Midwest

21.6

11.3

8.8

8.6

16.8

8.4

11.3

8.0

South

37.0

21.5

15.1

15.8

28.5

32.0

22.8

12.2

West

23.0

47.1

48.7

65.9

23.5

49.4

44.6

71.1

Foreign born
Of these, arrived in past 10 years

Educational attainment** (ages 25+)

Median annual personal earnings
Full-time, year-round workers
Household annual income
Median
Average household size (persons)
In poverty
Language***
Speaks English “very well”
Region of residence

* US Asians include mixed-race and mixed-group populations, regardless of Hispanic origin
** “High school or more” includes those who attained at least a high school diploma or an equivalent, such as a General Education Development
(GED) certificate
*** “Speaks English ‘very well’” includes those who speak only English at home
Source: Pew Research Center analysis of 2010 American Community Survey, Integrated Public Use Microdata Sample (IPUMS) files

Mass immigration from Japan did not occur until the 1890s when industrialists started to recruit
Japanese immigrants because Chinese immigrants were barred from entry due to the Chinese
Exclusion Act of 1882 (Pew Research Center, 2013). Although Japanese Americans were the
largest US Asian subgroup from 1910 to 1960, the immigration flow plummeted as a result of the
World War II and rising living standards in Japan. Consequently, Japanese Americans had older
median age than the other Asian subgroups (Table 4) as well as more cancer cases (Miller et al.,
2007; Gomez et al., 2013).
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Nativity, as an indicator for immigration status and acculturation, has been an important factor
affecting cancer incidence and survival among Asian Americans (Ladabaum et al., 2014; Chang
et al., 2010; Raz et al., 2008; Gomez, Kelsey, Glaser, Lee, & Sidney, 2004). The second-generation
Asian Americans are more acculturated than their parents, carrying a cancer profile approaching
to that of non-Hispanic whites while blurring the cancer health disparities among Asian Americans
(Gomez et al., 2010). However, the confounding effects from US-born Asian Americans is very
limited, as least for several decades from now, because the median age of the second-generation
Asians was just 17 years old in 2010 (Pew Research Center, 2013), far below 70 years old, the
average age at the time of cancer diagnosis (Haselkorn et al., 2015; American Cancer Society,
2016). In addition, the pace of new immigrants from Asia is faster than that of the secondgeneration Asians stride into “cancer age”. According to Statistical Portrait of the Foreign-Born
Population in the US, 2012, the proportion of foreign-born Asians will be higher when the current
US-born Asians reach their 70s (Pew Research Center, 2014).
Education attainment
Traditional Asian culture put especial value on education. Regardless of the debate of Asian
parenting and educational approach, Asian Americans have higher educational attainment and
more academic success than the national average, particularly in higher education. Findings from
the 2010 American Community Survey showed that 49% of Asian Americans had at least a
Bachelor’s degree compared with 28% of the US total population (Table 4). Yet, Vietnamese was
the only Asian subgroup having lower educational attainment than the US share at all three
educational levels. Noteworthy, Asian Indians had the highest educational attainment, 70% of
them had at least a Bachelor’s degree, approximately 20% higher than the second place Korean.
Educational attainment is remarkably higher among recent Asian immigrants. Among those who
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entered the US between 2007 and 2010, 61% of them held at least a Bachelor’s degree (Pew
Research Center, 2013). English proficiency among Asian Americans had a similar pattern to their
educational attainment (Table 4). Vietnamese had the lowest English proficiency, followed by
Chinese and Koreans. Japanese had the highest English proficiency mostly because of a lower
proportion of foreign-born. Individuals’ education attainment contributes to their socioeconomic
status and shapes their knowledge and attitude towards cancer prevention and screening (CDC,
2012b).
Income
Due to higher educational attainment and favored employment and occupational patterns, the
average personal income and household income among Asian Americans were higher than the US
shares (Table 4). Again, Vietnamese was the only Asian subgroup with an annual personal income
below the national average, although the annual household income was higher than the US share
due to a larger household size among Asian Americans. According to the Survey of Income and
Program Participation, median household wealth for Asian Americans was $83,500 in 2010, higher
than the national average of $68,529 (Pew Research Center, 2013). Nevertheless, Asian-American
wealth is not uniformly distributed among Asian subgroups. In 2010, Chinese (13.7%),
Vietnamese (14.7%), and Koreans (15.1%) were more likely to live below the poverty line than
the US baseline (12.8%) while Filipinos (6.2%) and Asian Indians (9.0%) were less likely to be
poor (Pew Research Center, 2013). Noticeable economic inequality partitions Asian Americans
into different levels of socioeconomic status, contributing to cancer health disparities among
specific Asian subgroups.
Region of residence
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In the 2010 Census, 46% of Asian Americans lived in the West, 22% in the South, 20% in the
Northeast, and 12% in the Midwest (Figure 3). The findings from the American Community
Survey in 2010 showed identical distribution (Table 4). Residential settlement patterns varied
greatly among Asian subgroups. Japanese (71%) and Filipinos (66%) were more likely to live in
the West, where was home to approximately half of Chinese, Vietnamese, and Koreans as well.
Asian Indians had more even distribution around the county. Unlike the other Asian subgroups,
the two largest shares of Asian Indians lived in the Northeast (31%) and South (29%). Region of
residence has been linked with variations observed in cancer incidence and survival (Laden et al.,
1997; CDC, 2015), partially due to differences in local health care quality and costs (Newhouse &
Garber, 2013).
The geographic variations, to some extent, also affect cancer research on racial disparities
among Asian Americans. SEER covers approximately 50% of the US Asian Americans but 73.2%
of them reside in the West, mostly in California. Therefore, data from the other quality cancer
registries where large Asian American population reside, such as Texas, New York, Florida,
Washington, and Illinois, will be a valuable addition to increase diversity of Asian Americans and
coverage of Asian Indians. Moreover, immigrants and ethnic minorities are prone to live in ethnic
enclaves with high proportions of residents from the same ethnic group (Osypuk, Diez Roux,
Hadley, & Kandula, 2009). Their cancer profiles will be approximate because of similar lifestyles
and SES (Keegan et al., 2010). Hence, a geographic region is a dynamic unit depending on the
total population size and distribution of Asian subgroups. A small unit, such as county, sometimes
is preferred to examine cancer health disparities among Asian Americans.
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Figure 3. Map of the United States, showing census regions and divisions; Source: US Census Bureau

Despite the diversity and heterogeneity of specific Asian subgroups, dominant cancer research
literature tends to aggregate Asian subgroups into one large group or combine with Pacific
Islanders. The most current national cancer reports – the Annual Report to the Nation on the Status
of Cancer 1975-2011 (Kohlers et al., 2015) and the United States Cancer Statistics 1999-2009
Cancer Incidence and Mortality Data – disappointedly adopted “Asian and Pacific Islander” to
address cancer burdens among Asian Americans. However, the model minority stereotype and
above-average cancer statistic obscure cancer health disparities and unmet public health needs
among specific Asian subgroups.
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Research on Cancer Health Disparities among Asian Americans
Overcoming cancer health disparities is one of the keystones to reduce the burden of cancer in
the US. While cardiovascular disease holds the leading cause of death in the US for decades, cancer
has been the number one killer among Asian Americans (Gomez et al., 2014). However, research
on cancer health disparities among Asian subgroups has been hampered due to the complexity and
difficulty in collecting data on race/ethnicity by cancer registries.
Population-based cancer registries in the US
Since the first cancer registry established at Yale-New Haven Hospital in 1926, populationbased cancer registries possesses a vital role in advancing cancer research and revealing cancer
health disparities in the US Today, the National Program of Cancer Registries (NPCR) of the CDC
and the SEER Program of the NCI, altogether covering the entire US, provide information on
cancer statistics in an effort to reduce the burden of cancer among the US population. The
NAACCR, working with CDC and NCI together, establishes guidelines for all state registries to
achieve compatible cancer data. The US population has experienced drastic increases in
racial/ethnic diversity over the last several decades due to immigration waves from Latin American
and Asia. However, the accuracy and completeness of cancer registry data on race/ethnicity have
been challenged by limited resources.
Population-based cancer registries obtain race/ethnicity data primarily from medical records.
Partially caused by inconsistent hospital policies and practices on collecting race/ethnicity data
(Gomez, Le, West, Satariano, & O'Connor, 2003), misclassification was moderate for Asians but
varied by Asian subgroup (Gomez & Glaser, 2006). In the on-going efforts to enhance
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identification of detailed Asian subgroups, the NAPIIA was developed (Hsieh, Pareti, & Chen,
2011) but has never been officially adopted by SEER or NPCR.
Another notable problem is the presence of Asian, not otherwise specified (NOS) in cancer
registry data, a category to which an Asian cancer case with unknown Asian subgroup is assigned.
With the rapid growth of Asian American population, the proportions of NOS have been steadily
rising over the last several decades. In SEER, the proportion increased from 1.2% in 1990 to 10.6%
in 2008 (Gomez et al., 2013) and reached 11.7% between 2009 and 2011. In NPCR, the proportion
of Asian, NOS is higher because of relatively lower data completeness. For example,
approximately 40% of Asian cases in Texas diagnosed between 2009 and 2011 were classified as
NOS. Currently, the most common method to treat this problem is pairwise deletion because NOS
cannot be included in any specific Asian subgroup (Miller et al., 2007; Gomez et al., 2013).
However, incidence rates for specific Asian subgroups might be underestimated because of
exclusion of these cases.
The majority of cancer researchers favored SEER data due to its reputation for accuracy,
completeness, and convenience, although it covers only approximately 50% of Asians in the US.
However, Asian Indians are relatively under-represented (39.4%) in SEER than the other Asian
subgroups (Table 5).
Table 5. Population estimates by Asian subgroup in SEER and the US, 2010*
Asian subgroup

SEER Population

US Population

Percentage

Chinese**

1,671,391

3,347,229

49.9

Filipino

1,657,524

2,555,923

64.9

Asian Indian

1,121,539

2,843,391

39.4

Vietnamese

786,540

1,548,449

50.8

Korean

720,344

1,423,784

50.6

Japanese

534,808

763,325

70.1

*Race-specific counts and percentages in this table are based on persons self-reporting only one race
Source: US Bureau of Census, Census 2010, Summary File 2
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Therefore, using SEER's population bases solely may not be able to provide a robust
assessment on cancer health disparities in Asian Americans, particularly in Asian Indians. The
addition of NPCR data is valuable to increase diversity of Asian Americans and coverage of Asian
Indians.
Population estimates
National data on cancer incidence and survival for detailed Asian subgroups are not routinely
available due to lack of accurate population estimates for Asian subgroups (McCracken et al.,
2007). The decennial US Census provides the most accurate population estimates for most cancer
research. The 2010 US Census question on race included seven separate response categories of
Asian subgroups and one area where respondents could write in detailed Asian subgroups not listed,
which allows each respondent to report multiple races (Figure 4).

Figure 4. Reproduction of the question on race from the 2010 Census

First, people who report only one detailed Asian subgroup, such as “Asian Indian”, are referred
to as “Asian alone with only one detailed Asian subgroup reported” (Figure 5). Respondents who
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report more than one detailed Asian subgroup, such as “Chinese and Filipino”, are referred to as
“Asian alone with two or more detailed Asian subgroups reported”. But each detailed Asian
subgroup will be counted once separately. Second, respondents who report one or more Asian
subgroup and one or more non-Asian race, such as “Chinese and Hawaiian”, or “Chinese, Filipino,
Hawaiian, and White”, are referred to as “Asian in combination with one detailed Asian subgroup
reported” or “Asian in combination with two or more detailed Asian subgroups reported”. Cancer
in multiracial Asian Americans is an emerging and important topic in cancer research because the
blend of cultures and lifestyles complicate cancer risk factors and alter their cancer profiles.
However, this topic is beyond the scope of the present study. Also, multiracial Asian Americans
are more likely to be the second-generation Asian immigrants after interracial marriage occurs.
Therefore, they are young and the least likely group to develop cancer (Pew Research Center,
2013).

Figure 5. Asian population by detailed group from the 2010 Census

In order to produce population estimates for specific Asian subgroups, the two Asian alone
categories have to be added up together. Gomez et al. (2013) adopted the mean of Asian alone and
Asian alone or in combination for each detailed Asian subgroup. Because each reported Asian
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subgroup in “Asian alone or in combination with two or more detailed Asian subgroups reported”
will be counted once separately, averaging the two groups will introduce repeated cases to the
population estimates. For example, only 346,672 respondents self-identified as Asian with two or
more detailed groups (Table 6). However, 709,212 cases were counted from this group, resulting
in an inflated population estimate by 2.5% and consequent underestimated rates. New method is
required to bridge population estimate by adjusting for repeated cases.
Table 6. Asian population by detailed groups, 2010
Asian subgroup

Asian Alone
One detailed group

Two or more detailed groups

Chinese

3,347,229

188,153

Filipino

2,555,923

94,050

Asian Indian

2,843,391

75,416

Vietnamese

1,548,449

84,268

Korean

1,423,784

39,690

Japanese

763,325

78,499

1,845,479

149,136

Total

14,327,580

709,212

Net Total

14,327,580

346,672

Other Asian

Source: US Bureau of Census, Census 2010, Summary File 1

Since the US Census is only available every 10 years. Statistical methods, such as linear
interpolation and extrapolation, are adopted to project population estimates for intercensal years
and postcensal years (Kwong et al., 2005; Gomez et al., 2013). These methods assume that
population growth is constant, in spite of the fact that the growth rates are changing all the time
and vary greatly by race/ethnicity. Therefore, cancer rates based on projected population estimates
are not accurate.
Cancer incidence disparities among Asian Americans
Asians have lower overall incidence compared to the national average, but they have higher
rates of cancers related to infectious agents and rising rates of cancers related to lifestyles (Kwong
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et al., 2005; McCracken et al., 2007; Miller et al., 2007; Gomez et al., 2013). Model minority
stereotype masks the urgent needs in cancer prevention and screening among US Asian Americans,
resulting in widening cancer health disparities among specific Asian subgroups.
Currently, only two recent literatures systematically examined cancer incidence disparities
among Asian subgroups. Gomez et al. (2013) investigated national cancer trends for specific Asian
subgroups using 1990-2008 SEER data, which provides valuable baseline data for the present
study (Table 7, 8). Miller et al. (2007) examined cancer incidence and mortality patterns among
specific Asian and Pacific Islander population using 1998-2002 (Table 9, 10). Incidence rates from
the two articles are both reported in Table 7-10. Given the identical patterns and similar rates,
results from Gomez et al. are discussed mostly due to newer data.
Table 7. Age-adjusted incidence rates by Asian subgroup and non-Hispanic white, men, 2004-2008
Race

All sites

Prostate

Lung

Colon/rectum

Liver

Stomach

Chinese

320.9

74.9

52.0

42.1

24.1

16.3

Filipino

385.1

117.2

68.4

47.8

17.1

-

Asian Indian and Pakistani

283.6

84.3

30.1

23.4

-

-

Vietnamese

367.5

56.0

73.4

41.1

58.5

21.2

Korean

400.0

63.5

57.5

58.2

34.9

52.5

Japanese

403.9

109.5

52.4

66.6

-

24.2

Non-Hispanic white

560.2

154.7

74.0

54.0

-

-

Incidence rate: annual cases per 100,000 persons. Age adjusted to the 2000 US standard population Source: Gomez et al., 2013

Table 8. Age-adjusted incidence rates by Asian subgroup and non-Hispanic white, women, 2004-2008
Race

All sites

Breast

Lung

Colon/rectum

Uterine

Thyroid

Chinese

263.3

78.8

29.9

35.7

14.3

12.2

Filipino

312.2

103.7

30.1

31.8

22.0

21.4

Asian Indian and Pakistani

250.1

88.3

12.4

18.8

16.4

11.9

Vietnamese

285.7

63.0

31.8

35.8

-

15.1

Korean

290.6

69.5

28.0

40.9

-

15.3

Japanese

307.5

104.9

27.9

43.0

20.0

-

Non-Hispanic white

440.0

135.3

56.6

40.6

26.2

-

Incidence rate: annual cases per 100,000 persons. Age adjusted to the 2000 US standard population. Source: Gomez et al., 2013
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Table 9. Age-adjusted incidence rates by Asian subgroup and non-Hispanic white, men, 1998-2002
Race

All sites

Prostate

Lung

Colon/rectum

Liver

Stomach

Chinese

348.8

84.8

53.0

54.0

24.0

18.3

Filipino

393.2

121.9

72.5

50.4

17.2

-

Asian Indian and Pakistani

292.1

98.4

30.8

23.1

-

-

Vietnamese

374.3

59.1

72.3

41.2

55.5

25.6

Korean

372.6

55.7

61.1

55.9

35.9

55.0

Japanese

422.4

115.0

49.8

75.9

-

29.3

Non-Hispanic white

587.0

170.0

89.2

65.6

-

-

Incidence rate: annual cases per 100,000 persons. Age adjusted to the 2000 US standard population Source: Miller et al., 2007

Table 10. Age-adjusted incidence rates by Asian subgroup and non-Hispanic white, women, 1998-2002
All sites

Breast

Lung

Colon/rectum

270.4

77.6

29.7

40.2

Endometriu
m
12.0

Thyroid

Chinese
Filipino

291.1

100.4

26.0

29.4

18.6

17.7

Asian Indian and Pakistani

238.1

82.1

13.1

18.8

13.5

-

Vietnamese

270.6

52.8

34.4

33.3

16.8

-

Korean

254.5

53.5

27.5

35.9

-

-

Japanese

342.4

126.5

24.7

51.9

20.4*

-

Non-Hispanic white

448.5

145.2

59.0

47.6

-

-

Race

-

Incidence rate: annual cases per 100,000 persons. Age adjusted to the 2000 US standard population. Source: Miller et al., 2007
*For Vietnamese, incidence rate for cervix and uteri was estimated instead of endometrium

Prostate cancer was the most common cancer for Asian American men except for Vietnamese
(Table 7, 9). The rates varied two-fold across the major six Asian subgroups. Filipino and Japanese
men had the highest rates, which were approximately 25% lower than non-Hispanic whites. Lung
cancer was the most common cancer among Vietnamese men with a comparable rate with nonHispanic whites and the second most common cancer among Chinese, Filipino, Asian Indian and
Pakistani men. Japanese and Korean men had highest colorectal cancer rates, which were higher
than non-Hispanic whites. Notably, in contrast with non-Hispanic whites, liver cancer and/or
stomach cancer were ranked as one of the five most common cancers among all male Asian
subgroups except for Asian Indian and Pakistani men. Vietnamese men had the highest liver cancer
rate while Korean men were disproportionately affected by stomach cancer.
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Breast cancer was the most common cancer for Asian American women (Table 8, 10). Japanese
and Filipino women had the highest rates, which were nearly 29% lower than non-Hispanic whites.
Colorectal cancer and lung cancer were the second and third most common cancer for Asian
American women. Vietnamese women had the highest rates of lung cancer, which were about 44%
lower than non-Hispanic whites. Japanese and Korean women had the highest rates of colorectal
cancer, which were higher than non-Hispanic whites. Unlike Asian American men, stomach cancer
was ranked as one of the five most common cancers among Korean and Japanese women only.
Liver cancer was the fourth most common cancer among Vietnamese women only. However,
thyroid cancer, which used to less affect Asian American women (Table 10), made the fifth most
common cancer for Asian American women with the only exception of Japanese and
disproportionately affected Filipino women.
Survival
Cancer survival is a more complex concept than mortality because it takes survival time after
diagnosis into account. In spite of sporadic research on cancer survival among Asian Americans,
variations in cancer survival have also been found among specific Asian subgroups.
Lin et al. (2002) examined survival difference of prostate, colorectal, breast, and cervical
cancer among Chinese, Japanese, and Filipinos using 1988-1994 SEER data. Filipino men were
more likely to be diagnosed with advanced stage prostate and colorectal cancer and had lower 5year survival rate. Chinese women were more likely to be diagnosed with advanced stage
colorectal cancer and had lowest 5-year survival rate. Chinese and Filipino women were more
likely to be diagnosed with advanced stage breast cancer and had lower 5-year survival rates.
Japanese women were less likely to be diagnosed with advanced stage cervical cancer but had
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lower survival rate. This article highlighted the importance of stage at diagnosis in predicting
cancer survival. Unfortunately, Lin et al. didn’t perform multivariate analysis to adjust for other
confounding covariates.
Le et al. (2009) analyzed colorectal cancer survival among major Asian subgroups using 19942003 California Cancer Registry data. Multivariate analyses were performed to detect racial
disparities among Asian subgroups. After adjustment for age, gender, grade, histology, site within
the colon, stage of diagnosis, insurance status, socioeconomic status, and treatment, only Filipino
and Chinese had significantly decreased risk of death than non-Hispanic whites.
Chang et al. (2009) investigated non–small-cell lung cancer survival among Asian subgroups
using 1988-2007 California Cancer Registry data. Asian American and Pacific Islanders
demonstrated better overall and disease-specific survival than non-Hispanic whites, but survival
varied greatly across Asian subgroups. Among women, Japanese had significantly poorer overall
and disease-specific survival than Chinese while South Asian women had significantly better
survival than Chinese. Among men, Japanese, Vietnamese had significantly poorer overall and
disease-specific survival than Chinese. Besides Asian subgroup, lower neighborhood
socioeconomic status, involvement with a non-university hospital, unmarried status, older age, and
earlier year of diagnosis significantly predicted poorer survival.
Cancer survival advantages have been found among Asian Americans (Chang et al., 2009; Ou
et al., 2009). However, this message might be misleading because cancer survival in Asians are
more likely to be overestimated due to more missing deaths resulting from problematic death
linkages (Pinheiro, Morris, Liu, Bungum, & Altekruse, 2014). Further research is indispensable
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to examine cancer survival disparities among Asian subgroups, especially in cancers
disproportionately affecting specific Asian Americans, such as stomach cancer.
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Summary
US Asian Americans are bearing heavy burden of cancer. Current research on cancer health
disparities among Asian Americans is relatively scarce for this rapidly growth population. The
cancer burden in Asian Americans is unique. Cancer is the leading cause of death only among
Asian Americans in the US Their cancer burden also is unusual. Asian Americans have higher
incidence and mortality rates of cancers of infectious origins. More importantly, their cancer
burden is unnecessary. The majority of cancers disproportionately affecting Asian Americans are
preventable and/or early-diagnosable by effective vaccination and timely screening.
In the on-going efforts to research cancer health disparities among specific Asian subgroups,
the dominant literature is rooted on SEER’s population bases and is troubled by underestimated
numerators and inflated denominators. Research on survival disparities is scattered and outdated.
Current literature misses data on important cancer sites and lacks of systematical comparisons
among major Asian subgroups and with racial/ethical majorities. With the newly-released SEER
and NPCR data and 2010 US Census, it is imperative to explore cancer health disparities among
Asian Americans because representative and accurate estimates in cancer incidence and survival
would facilitate priority assessment, better inform public health policies, and improve access to
quality healthcare and prevention.
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Chapter 3
Cancer Incidence among US Asian American Populations
Introduction
Asian Americans are the fastest growing racial/ethnic group in the United States (US Census,
2012a). Between 2000 and 2010, the Asian American population grew by 43%, from 10.2 million
to 14.7 million, which was more than four times faster than growth in the total US population (US
Census, 2012a). This has been fueled primarily by international immigration from Asia (US
Census, 2013). In 2010, 74% of Asian American adults were foreign-born; of those, 36%
immigrated in 2000 or later (US Census, 2012b; Pew Research Center, 2013). The most populous
Asian subgroup was Chinese, with 4 million people, followed by Filipino and Asian Indian with
3.4 million and 3.2 million people, respectively (Census, 2012a). The heterogeneous Asian
American population is comprised of distinct subgroups with differences in genetics, culture,
lifestyle, immigration and settlement experiences (Gomez et al., 2014). This diversity must be
explored to better understand disparities in cancer incidence among Asian subgroups and to
identify protective attributes as well as risk factors that can shape cancer intervention strategies.
Most cancer research aggregates Asian Americans into one single group, potentially blurring
important differences among specific Asian subgroups (Gomez et al., 2014). Some previous
studies using population-based cancer registry data have revealed clear differences in cancer
incidence among specific Asian subgroups (Cheng et al., 2014; Gomez et al., 2013; Miller et al.,
2007; McCracken et al., 2007; Giddings, Kwong, Parikh-Patel, Bates, & Snipes, 2012; Wang et
al., 2010; Carreon et al. 2008; Reynolds et al., 2011; Gomez et al., 2010; Liu et al., 2012). However,
these studies have a few limitations. Firstly, all reported national rates were based solely on data
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from the Surveillance, Epidemiology, and End Results (SEER) Program, whose catchment area
excludes some major metropolitan areas with large Asian American populations, such as New
York, Houston, and Chicago. These areas are only covered by the National Program of Cancer
Registries (NPCR). Secondly, Asian cancer cases in SEER with missing Asian subgroup category
were classified as not-otherwise-specified (NOS) and routinely excluded from incidence analyses,
leading to underestimated rates by subgroup. Also, without accurately accounting for these NOS
cases, which represented up to 13% of all Asians in 2008-2012 SEER data, comparisons among
the Asian subgroups as well as between these and the other US racial groups are possibly biased.
The final significant limitation of previous studies is the use of inflated population estimates due
to the inclusion of multiracial Asians in total Asian population. While bridging methods have been
widely used to compute population estimates for specific Asian subgroups (Cheng et al., 2014;
Gomez et al., 2013; Miller et al., 2007; McCracken et al., 2007; Giddings, Kwong, Parikh-Patel,
Bates, & Snipes, 2012; Wang et al., 2010; Carreon et al. 2008; Reynolds et al., 2011; Gomez et al.,
2010; Liu et al., 2012), these methods include multiracial Asians in combination with non-Asian
race(s) (e.g., Black), thus giving rise to misclassification in population estimates and possible
mismatches between numerators and denominators.
In this study, we directly address these limitations by (1) including cancer data from all major
states with large Asian populations, (2) imputing NOS cases, and (3) using population estimates
bridged between single Asian race and Asian in combination with other Asian race(s). Using 20092011 data, we estimate cancer incidence rates for each of the six largest Asian subgroups in the
US: Chinese, Filipino, Japanese, Korean, South Asian, and Vietnamese for 17 most common
cancer sites.
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Materials and Methods
Study Purpose
The purpose of this study is to investigate cancer incidence disparities among Asian Americans
in the US with pooled cancer registry data from SEER and NPCR.
Research Question
Do cancer incidence disparities exist among specific Asian subgroups?
Hypotheses
Hypothesis 1
H0: Overall cancer incidence rates do not vary between non-Hispanic whites and Asians
from 2009 to 2011
HA: Overall cancer incidence rates vary between non-Hispanic whites and Asians from
2009 to 2011
Hypothesis 2
H0: Overall cancer incidence rates do not vary between Asian subgroups from 2009 to
2011
HA: Overall cancer incidence rates vary between Asian subgroups from 2009 to 2011
Hypothesis 3
H0: Site-specific cancer incidence rates do not vary between non-Hispanic whites and
Asians 2009 to 2011
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HA: Site-specific cancer incidence rates vary between non-Hispanic whites and Asians
from 2009 to 2011
Hypothesis 4
H0: Site-specific cancer incidence rates do not vary between Asian subgroup from 2009
to 2011
HA: Site-specific cancer incidence rates vary between Asian subgroup from 2009 to 2011
Study Data
Cancer incidence data (2015 submission) on the 3-year period from January 1, 2009 through
December 31, 2011 were obtained from the eight US states with the largest population
concentration of Asian Americans: California, Florida, Hawaii, Illinois, New Jersey, New York,
Texas, and Washington state, accounted for 68% of the total Asian American population (10
million out of the 14.7 million total) in the US (Table 11).
All cases of malignant cancers, in addition to in situ urinary bladder cancers were included.
Seventeen most common cancer sites were classified as follows: oral cavity and pharynx, stomach,
colon and rectum, liver and intrahepatic bile duct, pancreas, lung and bronchus, breast, cervix uteri,
corpus uteri, ovary, prostate, urinary bladder, kidney and renal pelvis, thyroid, non-Hodgkin’s
lymphoma, leukemia, and all-other-sites combined. Due to the known high risk for nasopharynx
cancer among Asians, we also looked at this subcategory within oral cavity and pharynx separately
(Miller et al., 2008). Female breast cancer was further stratified using a cutoff age of 50 into
premenopausal and postmenopausal categories because they have different underlying risk factors
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which may vary by Asian subgroup. Cancer site was coded according to the International
Classification of Diseases for Oncology, Third Edition (ICD-O-3).
The North American Association of Central Cancer Registries (NAACCR) Standards for
Cancer Registries code Asian race in 12 different subgroups, including Asian Indian, Chinese,
Filipino, Hmong, Japanese, Kampuchean, Korean, Laotian, Pakistani, Thai, Vietnamese, and NOS
(NAACCR, 2016a). Unfortunately, other Asian subgroups, e.g. Malaysians, Indonesians, etc. are
not identified by a race descriptor and are therefore commonly classified as NOS, lumped together
with cases of the 11 racial subgroups described above for whom a specific subgroup is missing. In
our study, these cases for which there is no race descriptor were aggregated into a single category
called Other Specified Asian (OSA).
All Asian cases were included regardless of Hispanic ethnicity. Race 1 and Race 2 (NAACCR
items 160 and 161) were used as the Asian race indicator (NAACCR, 2016a). Asians cases
reporting non-Asian race(s) except white were excluded because Asian only takes precedence over
white in multiracial coding (NAACCR, 2016b). Asian Indian and Pakistani were aggregated into
one single category, South Asian, according to NAACCR coding protocol. Although too small to
be included in the aims of this study, smaller Hmong, Kampuchean, Laotian, and Thai populations
were aggregated into one Southeast Asian category in order to account for them in the NOS pool.
US non-Hispanic whites were used as the referent group.
NOS cases were reassigned by imputation models stratified by age, sex, cancer site, and
geographic region. We identified 12 geographic regions, one for each state except California,
which was divided into five regions due to its large Asian American population and an uneven
distribution of specific Asian subgroups (Table 11). We considered the boundary of the local
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cancer registries, the proportions of different Asian subgroups and geographical adjacency to
derive these 5 California regions: Los Angeles County, Bay Area Region (including Alameda,
Contra Costa, Marin, San Francisco and San Mateo Counties), Santa Clara Region (including
Monterey, San Benito, Santa Clara and Santa Cruz Counties), Greater California without Orange
County, and Orange County. The latter was carved out from Greater California due to a
substantially higher proportion of Vietnamese than other California regions.
Table 11. Selected states and respective cancer registries and geographic regions
State

SEER registry

California

Los Angeles Registry

NPCR registry

Los Angeles County

San Francisco-Oakland Registry

Bay Area Region†

San Jose-Monterey Registry

Santa Clara Region‡

Greater California Registry*

Greater California Registry*

*

*

Greater California Registry
Florida
Hawaii

Greater California§

Greater California Registry

Orange County

Florida Cancer Data System

Florida

Hawaii Registry

Hawaii

Illinois
New Jersey

Geographic region

Illinois State Cancer Registry
*

Illinois

New Jersey Registry

New Jersey

New York

New York Cancer Registry

New York

Texas

Texas Cancer Registry

Texas

Washington State Cancer Registry||

Washington

Washington

New Jersey Registry

*

Seattle-Puget Sound Registry

*

Funded by both SEER and NPCR
Bay Area Region includes Alameda, Contra Costa, Marin, San Francisco, and San Mateo Counties
‡
Santa Clara Region includes Monterey, San Benito, Santa Clara, and Santa Cruz Counties
§
Greater California includes Central California, Sacramento, Tri-County, Desert Sierra, Northern California, and San Diego/Imperial
||
Only non-SEER area data were obtained
†

To take into account the NOS cases in our incident counts we proceeded as follows. Birthplace
was used to enhance the identification of the 11 specified Asian subgroups as well as identify OSA
(e.g., a NOS case with a birthplace of China was recoded as Chinese; a NOS case with a birthplace
of Malaysia was recoded as OSA). In order to estimate the quantity of OSAs that could not be
identified by birthplace but would have been identified by a race specific descriptor had it existed
in the NAACCR standards, we used an average ratio between those with a specific race without a
matching birthplace and those of the same race but with a matching birthplace (e.g. Filipino race,
birthplace Philippines) among Filipinos, Koreans, Southeast Asians, and Vietnamese. The choice
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of these four subgroups was based on the similar history of more recent immigration to the US to
those of OSAs, such as Indonesia and Malaysia. The remaining NOS cases were reassigned by
stratified imputation models as performed in previous research on cancer risk (Pinheiro et al.,
2009).
Variables are defined as follows: age group j=1-5 for ages 0-19, 20-44, 45-59, 60-74, ≥75;
cancer site l=1-17 for oral cavity and pharynx, stomach,…, other-site combined; geographic region
m=1-12 for Los Angeles County, …, Florida; Asian subgroup i=1 for South Asian, 2 for Chinese,
3 for Japanese, 4 for Filipino, 5 for Korean, 6 for Vietnamese, 7 for Southeast Asian, 8 for OSA,
and 9 for NOS. D is the number of cases whose race matches birthplace, and d is the number of
cases whose race does not match birthplace.
For each age group j, cancer site l, and geographic region m, we defined the total (N) of a
specific Asian subgroup i as:
Nijlm = Dijlm + dijlm
Hence, the average ratio (AR) was:
7

ARjlm =[Σ
(dijlm /Dijlm)] /4
i=4
The estimate for OSAs that cannot be identified by birthplace and the total number of OSAs
was given by:
d8jlm = D8jlm ARjlm
N8jlm = D8jlm + d8jlm
We then defined the proportion (P) of each Asian subgroup i over total Asians as:
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7

Pijlm = Nijlm /(Σ Nijlm + N8jlm)
i=1

Given the uneven distribution of NOS cases by age, 18 age groups (k=1-18 for ages 0-4, 59, …, 80-84, ≥85) were used for proportionate partition. The average ratios and proportions based
on j were used for k when the corresponding age groups indexed by k overlap with those groups
indexed by j (e.g., j=1 when k=1-4). Hence, adjusted total (N*) of NOS cases was given by:
N*9klm = N9klm - D8klm ARjlm
Adjusted total of NOS cases were proportionately partitioned to each Asian subgroup as
follows:
N*iklm = Niklm + N*9klm Pijlm
Population data were derived from 2010 US Census. Since Asians that report several Asian
subgroups are counted several times in census counts, the sum of all specific Asian subgroups
exceeds the total Asian population1. To adjust this, we applied sex and age-specific proportions of
multiple-Asian-race counts for each subgroup to the net difference between the real total and
single-Asian-race counts to derive subgroup estimates.
Average annual cancer incidence rates per 100,000 persons were calculated with and without
stratified imputation for comparison, and age-standardized to the 2000 US Standard Population.
Corresponding 95% confidence intervals (CIs) were calculated with gamma intervals modification
(Tiwari, Clegg, & Zou, 2006). R 3.13 and SAS 9.3 were used for data analysis.
This study was approved by the University of Nevada, Las Vegas Institutional Review Board
(IRB), the Illinois Department of Public Health IRB, and the Washington State IRB. Data use
agreements were obtained from the SEER program, the New York Cancer Registry, the Texas
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Cancer Registry, the Illinois State Cancer Registry, the Washington State Cancer Registry, and the
Florida Cancer Data System.
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Results
A total of 90,709 Asian and 1,327,727 non-Hispanic white new cancer cases were diagnosed
from 2009 to 2011 in the eight states in our study (Table 12). California accounted for 52% of all
the Asian cases, followed by New York with 10%. Of Asian cancer cases, 15% were NOS (12%
in SEER and 23% in NPCR). Due to the uneven distribution of NOS cases, the increase in overall
incidence rates after stratified imputation varied considerably by Asian subgroup with the lowest
increment of 8% observed in Japanese men and the highest of 25% in South Asian women (Table
13 and 14). Within each Asian subgroup, the increment also differed substantially by cancer site.
Table 12. Distribution of Asian and non-Hispanic white cancer cases before and after stratified imputation, 8 states, 2009-2011

California
Florida
Hawaii
Illinois
New Jersey
New York
Texas
Washington
Total

Chinese

Filipino

Japanese

Korean

South
Asian

Vietnamese

Other
Asian*

Asian
NOS

Before

11,703

12,092

4,133

3,610

3,067

4,749

1,440

5,922

After

13,132

13,699

4,604

4,018

3,593

5,393

2,277

0

Before

247

417

113

116

641

321

67

970

After

373

640

163

179

902

469

166

0

Before

1,130

2,826

4,755

423

19

73

46

92

After

1,140

2,858

4,799

427

19

74

47

0

Before

457

766

129

402

1,246

142

82

986

After

594

995

165

518

1,598

177

163

0

Before

856

1,029

123

701

1,651

155

28

556

After

964

1,143

134

774

1,831

172

81

0

Before

5,290

1,119

272

954

2,865

284

200

1828

After

5,974

1,277

312

1,083

3,362

328

476

0

Before

485

402

157

282

1,077

872

95

2029

After

828

630

227

431

1,710

1,333

240

0

Before

549

705

484

528

237

430

228

1056

After

727

945

614

678

333

549

371

0

Before

20,717

19,356

10,166

7,016

10,803

7,026

2,186

13,439

After

23,732

22,187

11,018

8,108

13,348

8,495

3,821

0

Asian
Total

NH
White

46,716

297,448

2,892

244,747

9,364

5,910

4,210

150,289

5,099

110,185

12,812

233,818

5,399

197,509

4,217

87,821

90,709 1,327,727

*

Other Asian before stratified imputation includes Hmong, Kampuchean, Laotian, and Thai; Other Asian after stratified imputation includes
Hmong, Kampuchean, Laotian, Thai, and Other Specified Asian

The overall cancer incidence rate for Asian American men was 336.5/100,000 person-years;
for women it was 299.6/100,000 (Table 15 and 16). This was nearly 38% and 33% lower than nonHispanic white men and women, respectively. For the majority of cancer sites, incidence rates
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were lower among all Asian American populations than non-Hispanic whites. However, compared
to non-Hispanic whites, Asian Americans had significantly higher rates for three infection-related
cancers – nasopharyngeal, liver, and stomach cancers.
Among the Asian subgroups, Filipinos ranked highest in overall cancer incidence for men and
second for women, partially due to high prostate and breast cancer rates. They also had the highest
thyroid cancer rates (9.7/100,000 in men and 28.5/100,000 in women). Also with high prostate and
breast cancer rates, Japanese ranked second in men and first in women for overall cancer incidence.
Additionally, colorectal cancer rates were highest in this group (59.5/100,000 in men and
40.5/100,000 in women). The lowest overall cancer incidence rates were found in South Asian
men and Korean women, while Chinese men and women had the second lowest overall rates.
Remarkably, the Chinese subgroup had the highest nasopharyngeal cancer rates (8.0/100,000 in
men and 2.5/100,000 in women) and the Koreans had the highest stomach cancer rates
(37.8/100,000 in men and 18.8/100,000 in women), significantly higher than any other Asian
populations. Unlike other subgroups, South Asians had low nasopharyngeal, stomach, and liver
cancer rates, similar to those of non-Hispanic whites. Notably, they also showed markedly low
colorectal (28.1/100,000 in men and 22.3/100,000 in women) and lung cancer rates (27.1/100,000
in men and 14.9/100,000 in women). The Vietnamese subgroup had the highest liver cancer rates
(52.8/100,000 in men and 15.5/100,000 in women) as well as the highest cervical cancer rate
(9.0/100,000) among Asian subgroups.
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Table 13. Age adjusted cancer incidence rates before stratified imputation and 95% confidence intervals (CIs) by Asian subgroup and non-Hispanic whites, 2009-2011, men*
Chinese

Oral
Nasopharynx

Filipino

Japanese

Korean

South Asian

Vietnamese

Asian Total

NH White

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

12.0

(10.9-13.2)

8.2

(7.1-9.4)

10.8

(9.0-12.9)

5.7

(4.4-7.4)

12.8

(11.1-14.6)

9.8

(8.1-11.6)

11.7

(11.1-12.3)

19.0

(18.7-19.2)
(0.6-0.7)

4.4

(3.8-5.2)

2.9

(2.3-3.7)

0.7

(0.2-1.7)

0.8

(0.4-1.6)

0.8

(0.4-1.5)

4.1

(3.1-5.4)

4.1

(3.8-4.5)

0.6

Stomach

15.7

(14.4-17.1)

7.4

(6.3-8.6)

16.9

(14.8-19.4)

35.0

(31.4-39.0)

7.2

(5.9-8.6)

13.9

(11.6-16.6)

15.9

(15.2-16.7)

8.2

(8.0-8.3)

Colorectal

36.7

(34.7-38.8)

41.8

(39.2-44.6)

54.8

(50.7-59.2)

42.5

(38.5-46.8)

23.7

(21.2-26.3)

39.0

(35.3-43.1)

43.1

(41.9-44.3)

47.5

(47.1-47.8)

Liver

20.9

(19.4-22.4)

16.2

(14.6-18.0)

13.1

(11.2-15.3)

23.8

(21.0-27.0)

8.9

(7.5-10.4)

48.0

(44.0-52.3)

22.4

(21.6-23.2)

10.1

(9.9-10.3)
(14.3-14.8)

Pancreas

9.8

(8.8-10.9)

9.8

(8.6-11.2)

13.9

(11.9-16.2)

11.4

(9.3-13.8)

7.1

(5.7-8.7)

9.5

(7.7-11.6)

10.8

(10.2-11.5)

14.6

Lung

47.4

(45.1-49.8)

58.2

(55.0-61.6)

42.6

(39.1-46.4)

40.6

(36.5-45.0)

24.0

(21.5-26.8)

59.6

(54.8-64.7)

49.6

(48.3-51.0)

75.3

(74.8-75.8)

Prostate

53.2

(50.8-55.6)

90.0

(86.1-93.9)

82.1

(77.1-87.3)

41.1

(37.2-45.3)

62.3

(58.5-66.3)

41.2

(37.3-45.3)

74.5

(72.9-76.1)

130.2

(129.6-130.8)

Bladder

13.3

(12.1-14.6)

10.5

(9.2-12.1)

19.4

(17.1-22.0)

19.2

(16.4-22.3)

13.6

(11.7-15.7)

8.0

(6.3-10.1)

15.8

(15.1-16.6)

41.4

(41.0-41.7)

Kidney

8.5

(7.6-9.6)

13.5

(12.1-15.1)

14.2

(12.1-16.7)

10.9

(8.9-13.2)

9.3

(7.9-10.8)

7.2

(5.7-9.0)

12.0

(11.4-12.6)

22.2

(21.9-22.4)

Thyroid

5.9

(5.2-6.8)

8.2

(7.1-9.4)

3.3

(2.3-4.6)

6.8

(5.4-8.5)

4.5

(3.7-5.4)

4.1

(3.0-5.4)

6.8

(6.4-7.3)

8.1

(7.9-8.3)

14.0

(12.8-15.3)

18.0

(16.3-19.9)

15.3

(13.1-17.8)

10.2

(8.3-12.4)

15.5

(13.5-17.7)

14.4

(12.2-17.0)

16.7

(16.0-17.5)

25.2

(25.0-25.5)

6.9

(6.1-7.9)

10.7

(9.3-12.2

9.7

(7.9-11.9)

7.1

(5.6-9.0)

11.4

(9.8-13.3)

12.6

(10.5-15.0)

10.5

(9.9-11.1)

18.6

(18.4-18.9)

NHL
Leukemia
Other-sites combined
All-sites combined
*

35.1

(33.2-37.2)

41.7

(39.0-44.4)

45.2

(41.3-49.5)

41.1

(37.1-45.4)

47.4

(44.0-51.0)

41.1

(37.1-45.3)

46.6

(45.4-47.9)

121.7

(121.1-122.3)

279.5

(274.0-285.1)

334.2

(326.7-341.9)

341.5

(331.1-352.1)

295.5

(284.7-306.5)

247.7

(239.8-255.7)

308.4

(297.6-319.5)

336.5

(333.1-339.8)

541.9

(540.6-543.3)

Rates are average annual per 100,000 age standardized to the 2000 US population. Oral= oral cavity and pharynx; Liver= liver and intrahepatic bile duct; Lung=lung and bronchus; Bladder=urinary bladder; Kidney= kidney and
renal pelvis; NHL=non-Hodgkin lymphoma
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Table 14. Age adjusted cancer incidence rates before stratified imputation and 95% confidence intervals (CIs) by Asian subgroup and non-Hispanic whites, 2009-2011, women*
Chinese

Oral
Nasopharynx
Stomach
Colorectal
Liver
Pancreas

Filipino

Japanese

Korean

South Asian

Vietnamese

Asian Total

NH White

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

Rate

(95% CI)

5.2

(4.6-6.0)

3.4

(2.9-4.1)

3.9

(3.0-5.0)

1.9

(1.2-2.7)

5.4

(4.4-6.6)

4.7

(3.6-6.1)

4.9

(4.6-5.3)

7.0

(6.9-7.2)

1.7

(1.3-2.2)

0.9

(0.7-1.3)

0.4

(0.2-1.0)

0.3

(0.1-0.7)

0.4

(0.1-0.9)

1.7

(1.1-2.6)

1.3

(1.1-1.5)

0.2

(0.2-0.3)

8.3

(7.4-9.2)

4.1

(3.4-4.8)

10.0

(8.7-11.6)

17.1

(15.1-19.4)

4.5

(3.5-5.6)

9.7

(8.0-11.7)

8.9

(8.4-9.4)

3.7

(3.6-3.8)

27.4

(25.8-29.0)

28.3

(26.6-30.1)

37.5

(34.7-40.5)

30.0

(27.3-32.9)

17.7

(15.7-19.9)

28.0

(25.1-31.1)

31.6

(30.7-32.5)

36.5

(36.2-36.8)

7.5

(6.7-8.4)

5.5

(4.7-6.3)

6.8

(5.7-8.1)

9.1

(7.6-10.8)

4.1

(3.2-5.1)

13.4

(11.3-15.8)

8.1

(7.6-8.6)

3.4

(3.3-3.5)
(10.8-11.1)

7.2

(6.4-8.0)

8.5

(7.5-9.5)

11.7

(10.3-13.5)

9.1

(7.6-10.8)

5.0

(3.9-6.2)

7.3

(5.8-9.2)

9.0

(8.6-9.5)

10.9

Lung

28.4

(26.8-30.1)

26.8

(25.1-28.5)

28.2

(25.9-30.8)

24.9

(22.4-27.6)

12.7

(11.0-14.6)

28.2

(25.2-31.4)

28.6

(27.8-29.5)

59.4

(59.0-59.8)

Breast

70.3

(67.8-72.8)

95.2

(92.2-98.3)

114.1

(108.7-119.8)

63.8

(60.0-67.8)

85.3

(81.4-89.4)

56.4

(52.6-60.3)

94.5

(93.0-96.0)

134.4

(133.8-135.1)

Premenopausal

24.1

(22.7-25.7)

27.9

(26.2-29.7)

37.3

(33.8-41.2)

23.5

(21.3-26.0)

24.5

(22.7-26.3)

20.4

(18.3-22.7)

30.1

(29.3-31.0))

34.3

(33.9-34.6)

Postmenopausal

46.1

(44.1-48.1)

67.3

(64.8-69.9)

76.8

(72.7-81.1)

40.3

(37.3-43.4)

60.9

(57.4-64.6)

36.0

(32.9-39.3)

64.4

(63.2-65.6)

100.2

(99.7-100.7)

4.9

(4.3-5.6)

6.3

(5.5-7.1)

5.7

(4.5-7.3)

6.2

(5.1-7.6)

4.6

(3.7-5.6)

7.7

(6.2-9.3)

6.5

(6.1-6.9)

7.5

(7.3-7.6)

13.0

(12.0-14.1)

22.0

(20.5-23.5)

20.7

(18.4-23.1)

7.8

(6.5-9.3)

17.6

(15.8-19.6)

10.9

(9.3-12.7)

18.7

(18.0-19.3)

26.6

(26.3-26.9)

Ovary

7.7

(6.9-8.6)

8.7

(7.7-9.7)

7.5

(6.1-9.1)

7.2

(6.0-8.7)

10.9

(9.5-12.5)

8.2

(6.7-9.9)

9.7

(9.3-10.2)

13.1

(12.9-13.3)

Bladder

3.9

(3.4-4.6)

2.4

(1.9-3.0)

4.6

(3.7-5.7)

2.5

(1.8-3.6)

4.1

(3.1-5.3)

2.2

(1.4-3.2)

3.9

(3.6-4.2)

10.3

(10.1-10.4)

Kidney

4.2

(3.6-4.8)

5.1

(4.4-5.9)

5.4

(4.3-6.7)

3.6

(2.7-4.8)

4.5

(3.6-5.6)

3.7

(2.7-4.9)

5.3

(4.9-5.6)

11.1

(11.0-11.3)

Thyroid

16.8

(15.6-18.1)

23.5

(22.0-25.2)

9.7

(8.0-11.7)

18.2

(16.2-20.4)

14.3

(12.9-15.8)

14.3

(12.5-16.4)

21.5

(20.8-22.2)

22.4

(22.1-22.7)

NHL

9.0

(8.1-9.9)

12.3

(11.2-13.6)

10.9

(9.4-12.6)

7.1

(5.8-8.6)

9.7

(8.2-11.3)

9.7

(8.0-11.6)

11.7

(11.2-12.3)

17.3

(17.0-17.5)

Leukemia

4.8

(4.1-5.5)

7.0

(6.1-7.9)

6.0

(4.5-7.7)

3.3

(2.4-4.4)

7.0

(5.8-8.3)

6.4

(5.1-8.0)

6.5

(6.1-6.9)

11.4

(11.2-11.5)

Cervix Uteri
Corpus and uterus

Other-sites combined
All-sites combined

23.5

(22.0-25.0)

26.3

(24.6-28.0)

28.1

(25.3-31.2)

25.2

(22.6-28.0)

33.2

(30.5-36.2)

28.4

(25.5-31.6)

30.3

(29.4-31.2)

74.2

(73.8-74.7)

242.1

(237.4-246.8)

285.3

(279.9-290.8)

310.8

(302.0-319.8)

237.2

(229.5-245.0)

240.6

(233.6-247.8)

239.1

(230.7-247.8)

299.6

(296.9-302.3)

449.3

(448.2-450.4)

*

Rates are average annual per 100,000 age standardized to the 2000 US population. Oral= oral cavity and pharynx; Liver= liver and intrahepatic bile duct; Lung=lung and bronchus; Bladder=urinary bladder; Kidney= kidney and
renal pelvis; NHL=non-Hodgkin lymphoma
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Table 15. Age adjusted cancer incidence rates and 95% confidence intervals (CIs) by Asian subgroup and non-Hispanic whites, 2009-2011, men*
Chinese
N Rate
Oral
Nasopharynx
Stomach
Colorectal
Liver
Pancreas

513

13.5

Filipino
(95% CI)

(12.4-14.8)

N Rate

Japanese
(95% CI)

254

9.1

(8.0-10.4)

N Rate
144

11.6

Korean

(95% CI)

N Rate

(9.7-13.8)

72

6.5

South Asian
(95% CI)
(5.0-8.2)

N Rate

(95% CI)

363

15.3

(13.4-17.3)

Vietnamese
N Rate
168

12.0

(95% CI)
(10.2-14.1)

Asian Total
N Rate
1,596

11.7

NH White

(95% CI)
(11.1-12.3)

N Rate

(95% CI)

24,690

19.0

(18.7-19.2)
(0.6-0.7)

299

8.0

(7.1-9.0)

98

3.5

(2.8-4.3)

8

0.8

(0.3-1.8)

11

0.9

(0.4-1.7)

27

1.1

(0.7-1.6)

85

5.9

(4.7-7.4)

567

4.1

(3.8-4.5)

685

0.6

612

17.1

(15.7-18.5)

183

8.0

(6.8-9.3)

255

18.0

(15.8-20.5)

411

37.8

(34.1-41.9)

180

8.0

(6.7-9.5)

168

15.8

(13.3-18.7)

1,894

15.9

(15.2-16.7)

10,280

8.2

(8.0-8.3)

1,509

41.7

(39.6-43.9) 1,175

46.6

(43.8-49.5)

768

59.5

(55.2-64.0)

555

49.5

(45.2-54.0)

593

28.1

(25.5-31.0)

560

46.2

(42.0-50.5)

5,415

43.1

(41.9-44.3)

59,446

47.5

(47.1-47.8)

869

22.9

(21.4-24.5)

433

17.5

(15.8-19.3)

188

13.8

(11.9-16.1)

304

26.3

(23.3-29.6)

235

10.3

(8.8-11.9)

681

52.8

(48.7-57.3)

2,947

22.4

(21.6-23.2)

13,486

10.1

(9.9-10.3)

(9.3-11.5)

(14.3-14.8)

361

10.4

261

10.9

(9.5-12.3)

199

14.8

(12.7-17.1)

131

12.6

(10.4-15.1)

149

8.0

(6.5-9.6)

119

10.4

(8.5-12.6)

1,272

10.8

(10.2-11.5)

18,554

14.6

Lung

1,783

51.2

(48.8-53.6) 1,458

62.9

(59.5-66.4)

598

44.1

(40.5-48.0)

437

43.7

(39.4-48.2)

510

27.1

(24.4-30.0)

751

67.0

(61.9-72.4)

5,751

49.6

(48.3-51.0)

95,679

75.3

(74.8-75.8)

Prostate

2,280

63.0

(60.4-65.7) 2,693 105.2 (101.0-109.4) 1,174

90.1

(84.9-95.6)

551

49.3

(45.0-53.8) 1,714

80.6

(76.3-85.1)

615

53.3

(48.9-58.0)

9,311

74.5

(72.9-76.1) 174,028 130.2

(129.6-130.8)

Bladder

520

15.2

(13.9-16.6)

280

12.3

(10.9-13.9)

289

21.0

(18.6-23.7)

217

21.7

(18.7-25.0)

308

16.8

(14.6-19.1)

110

9.9

(8.0-12.1)

1,780

15.8

(15.1-16.6)

51,709

41.4

(41.0-41.7)

Kidney

363

9.9

(8.9-11.0)

421

15.7

(14.1-17.3)

192

15.5

(13.3-18.0)

135

12.3

(10.2-14.7)

280

11.6

(10.0-13.2)

115

8.7

(7.1-10.6)

1,562

12.0

(11.4-12.6)

28,013

22.2

(21.9-22.4)

Thyroid

263

6.9

(6.1-7.8)

271

9.7

(8.5-11.0)

41

3.7

(2.6-5.2)

108

8.3

(6.8-10.1)

186

5.8

(4.9-6.8)

75

5.3

(4.1-6.7)

974

6.8

(6.4-7.3)

9,425

8.1

(7.9-8.3)

NHL

557

15.6

(14.3-16.9)

498

20.4

(18.5-22.3)

215

16.9

(14.6-19.5)

131

11.8

(9.7-14.1)

381

18.0

(15.8-20.3)

204

17.1

(14.7-19.9)

2,070

16.7

(16.0-17.5)

30,855

25.2

(25.0-25.5)

(7.1-9.0)

285

12.2

(10.7-13.8)

125

10.5

(8.6-12.8)

93

8.3

(6.6-10.2)

295

13.4

(11.6-15.4)

175

14.9

(12.6-17.5)

1,298

10.5

(9.9-11.1)

22,178

(37.8-42.1) 1,165

47.0

(44.2-49.9)

609

49.7

(45.5-54.2)

500

46.2

(42.0-50.7) 1,256

54.8

(51.1-58.6)

565

48.4

(44.1-53.0)

5,825

46.6

Leukemia
Other-sites combined
All-sites combined

279

8.0

1,409

39.9

18.6

(18.4-18.9)

(45.4-47.9) 146,674 121.7

(121.1-122.3)

11,318 315.3 (309.5-321.3) 9,377 377.4 (369.4-385.5) 4,798 369.1 (358.3-380.2) 3,644 334.1 (322.7-345.8) 6,450 297.7 (289.1-306.4) 4,306 361.9 (350.2-373.8) 41,695 336.5 (333.1-339.8) 685,017 541.9

(540.6-543.3)

*

Rates are average annual per 100,000 age standardized to the 2000 US population. Oral= oral cavity and pharynx; Liver= liver and intrahepatic bile duct; Lung=lung and bronchus; Bladder=urinary bladder; Kidney= kidney and renal pelvis; NHL=non-Hodgkin
lymphoma; Numbers of cases may not add up to total due to rounding

43

Table 16. Age adjusted cancer incidence rates and 95% confidence intervals (CIs) by Asian subgroup and non-Hispanic whites, 2009-2011, women*
Chinese
N Rate
Oral
Nasopharynx
Stomach
Colorectal
Liver
Pancreas

268

6.0

108

2.5

399

9.2

1,372 31.3
351

8.3

338

8.0

Filipino
(95% CI)
(5.3-6.8)

N Rate

Japanese
(95% CI)

N Rate

3.8

(3.2-4.5)

(2.0-3.0)

41

1.1

(0.8-1.5)

6

0.4

(0.1-0.9)

(8.3-10.2)

166

4.5

(3.8-5.2)

242

10.7

(9.3-12.4)

(29.7-33.0) 1,201 31.6

(29.8-33.5)

819

40.5

(37.5-43.6)

545 34.4

(5.0-6.7)

161

7.0

(5.9-8.3)

209

5.8

(7.2-8.9)

337

4.1

(3.2-5.3)

N Rate

145

(7.4-9.2)

80

Korean

(95% CI)

34

2.1

5

0.3

288 18.8

144

9.7

South Asian
(95% CI)
(1.4-3.0)

N Rate

(95% CI)

Vietnamese
N Rate

140

6.5

(5.4-7.8)

81

5.6

(0.1-0.8)

8

0.4

(0.1-0.8)

27

1.9

(16.7-21.2)

106

5.3

(4.2-6.6)

138

11.2

(31.5-37.5)

444

22.3

(20.0-24.7)

466

34.2

(8.1-11.5)

96

4.7

(3.7-5.8)

188

15.5

(95% CI)
(4.4-7.0)

Asian Total
N Rate

NH White

(95% CI)

801

4.9

(4.6-5.3)

(1.2-2.8)

211

1.3

(9.3-13.4)

1,384

8.9

(31.0-37.7)

5,037

31.6

(30.7-32.5)

(13.3-18.0)

1,244

8.1

(7.6-8.6)

N Rate

(95% CI)

10,145

7.0

(6.9-7.2)

(1.1-1.5)

300

0.2

(0.2-0.3)

(8.4-9.4)

5,779

3.7

(3.6-3.8)

56,042 36.5

(36.2-36.8)

5,125

3.4

(3.3-3.5)

9.4

(8.4-10.5)

281

12.4

(10.9-14.2)

150 10.0

(8.4-11.8)

119

6.4

(5.2-7.7)

97

8.4

(6.7-10.3)

1,370

9.0

(8.6-9.5)

17,407 10.9

(10.8-11.1)

Lung

1,370 31.7

(30.0-33.4) 1,100 29.4

(27.7-31.3)

669

30.5

(28.1-33.1)

426 27.9

(25.3-30.8)

279

14.9

(13.0-17.0)

409

31.7

(28.6-35.1)

4,439

28.6

(27.8-29.5)

91,035 59.4

(59.0-59.8)

Breast

3,773 82.8

(80.1-85.5) 4,562 111.3 (108.0-114.7) 2,065 127.8 (122.0-133.8) 1,307 75.6

(71.4-79.8) 2,566 106.3 (101.9-110.9) 1,147

72.2

(67.9-76.6) 16,022

94.5

(93.0-96.0) 188,181 134.4 (133.8-135.1)

Premenopausal

1,251 28.8

(27.2-30.5) 1,179 33.2

(31.3-35.1)

462

42.7

(38.9-46.8)

468 27.9

(25.4-30.6)

931

31.0

(29.0-33.1)

439

26.4

(24.0-29.1)

4,949

30.1

(29.3-31.0)

31,961 34.3

(33.9-34.6)

Postmenopausal

2,522 53.9

(51.8-56.1) 3,383 78.1

(75.4-80.9) 1,603

839 47.7

(44.4-51.1) 1,635

(42.2-49.4) 11,073

64.4

(63.2-65.6) 156,220 100.2

(99.7-100.7)

85.1

(80.8-89.6)

75.4

(71.4-79.4)

708

45.7

(6.4-8.1)

85

6.6

(5.2-8.3)

119

7.2

(5.9-8.6)

135

5.5

(4.5-6.6)

132

9.0

(7.5-10.8)

1,094

6.5

(6.1-6.9)

(14.2-16.5) 1,109 26.5

(24.9-28.1)

379

22.8

(20.5-25.4)

171

9.6

(8.2-11.2)

519

22.0

(20.0-24.2)

230

14.3

(12.4-16.3)

3,250

18.7

(9.1-11.1)

138

8.3

(6.9-10.1)

147

8.8

(7.4-10.4)

319

13.5

(11.9-15.2)

147

10.3

(8.6-12.2)

1,627

(2.3-3.5)

118

5.0

(4.1-6.1)

46

3.3

(2.4-4.5)

92

5.3

(4.2-6.6)

33

2.8

(1.9-4.0)

593

6.0

(5.3-6.9)

113

6.0

(4.8-7.4)

65

4.2

(3.2-5.4)

130

5.8

(4.8-7.0)

66

4.6

(3.5-5.9)

843

(19.4-22.2) 1,108 28.5

(26.8-30.3)

153

11.6

(9.7-13.9)

408 23.2

(21.0-25.6)

624

19.9

(18.3-21.7)

318

19.3

(17.2-21.7)

3,670

(12.9-15.4)

249

11.8

(10.2-13.6)

129

8.2

(6.8-9.7)

274

12.4

(10.8-14.2)

167

12.1

(10.3-14.2)

1,884

7.8

(6.9-8.8)

94

6.4

(4.8-8.2)

60

4.0

(3.0-5.2)

195

8.7

(7.3-10.1)

111

7.9

(6.4-9.5)

(25.2-28.3) 1,068 29.6

(27.8-31.5)

574

31.1

(28.1-34.3)

425 29.0

(26.2-32.0)

862

40.1

(37.1-43.3)

462

34.1

(30.9-37.5)

249

Corpus and uterus

730 15.3

Ovary

414

9.0

(8.1-9.9)

395 10.1

Bladder

190

4.5

(3.8-5.2)

101

2.8

Kidney

211

4.9

(4.3-5.6)

232

Thyroid

920 20.8

NHL

463 10.5

Leukemia

228

Other-sites combined

5.6

7.2

Cervix Uteri

5.6

1,138 26.7

(4.9-6.4)

(9.5-11.5)
(4.8-6.4)

280

528 14.1
269

8,436

7.5

(7.3-7.6)

(18.0-19.3)

38,969 26.6

(26.3-26.9)

9.7

(9.3-10.2)

18,634 13.1

(12.9-13.3)

3.9

(3.6-4.2)

16,175 10.3

(10.1-10.4)

5.3

(4.9-5.6)

15,937 11.1

(11.0-11.3)

21.5

(20.8-22.2)

25,325 22.4

(22.1-22.7)

11.7

(11.2-12.3)

25,493 17.3

(17.0-17.5)

998

6.5

(6.1-6.9)

16,132 11.4

(11.2-11.5)

4,758

30.3

(29.4-31.2) 103,894 74.2

(73.8-74.7)

12,414 280.1 (275.2-285.2) 12,81 328.6 (322.8-334.4) 6,218 342.7 (333.5-352.3) 4,464 275.9 (267.7-284.4) 6,898 299.6 (291.8-307.6) 4,189 293.2 (283.9-302.7) 49,014 299.6 (296.9-302.3) 642,710 449.3 (448.2-450.4)
0
*
Rates are average annual per 100,000 age standardized to the 2000 US population. Oral= oral cavity and pharynx; Liver= liver and intrahepatic bile duct; Lung=lung and bronchus; Bladder=urinary bladder; Kidney= kidney and renal pelvis; NHL=non-Hodgkin
lymphoma; Numbers of cases may not add up to total due to rounding
All-sites combined
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Discussion
Our study found that Asian Americans have lower overall cancer incidence rates than nonHispanic whites, especially for the four most common cancers: prostate, breast, colorectal, and
lung. However, in comparison to non-Hispanic whites, Asian Americans are disproportionately
affected by infection-related cancers, such as nasopharynx, liver and stomach cancers, but notably
not cervical cancer. These findings are consistent with previous research (Gomez et al., 2013;
Miller et al., 2008; McCracken et al., 2007), although our updated data and new methodology
reveal some new cancer patterns among specific Asian subgroups.
The three highest cancer rates in Asian Americans are prostate, lung and colorectal in men,
and breast, colorectal and lung in women. There is considerable variation across Asian subgroups
but overall risk for these four cancers is lower than in non-Hispanic whites.
Specific cancer differences
Prostate cancer rates were highest among Filipino and Japanese men, but still 19% and 31%
lower than rates of non-Hispanic whites. Vietnamese and Korean subgroups showed the lowest
risk of prostate cancer among all Asians. Few risk factors are known for prostate cancer except for
age and African ancestry. Asian populations traditionally show low risk for this cancer (Gomez et
al., 2013; Miller et al., 2008; McCracken et al., 2007) but in Western countries like the US
incidence is mostly driven by the extent of prostate-specific antigen (PSA) screening coverage
(Delfino, Ferrini, Taylor, Howe, & Anton-Culver, 1998), which is currently not recommended on
a population basis. In clear relation with their incidence rates, it is not surprising that Filipino and
Japanese men have been found to have the highest PSA screening rates (48% and 50%,
respectively) while Vietnamese and Korean men have the lowest (13% and 22%) among all Asian
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subgroups in the California Health Interview Survey (California Health Interview Survey, 2015).
In the literature, the high incidence of prostate cancer for Filipinos among Asian subgroups has
been related to their lower consumption of non-fermented soy products (Matias & Raymundo,
2014). These products are popular in traditional Asian diets and have been associated with a 25%30% reduced risk for prostate cancer (Hwang, Kim, Jee, Kim, & Nam, 2009; Yan & Spitznagel,
2009).
Breast cancer was the leading cancer among women for all Asian subgroups, with Japanese
women having a risk comparable to that of non-Hispanic white women, mostly attributable to a
significantly higher rate among premenopausal Japanese women. Unlike other Asian subgroups,
two-thirds of the Japanese American population is US-born (US Census, 2012b). Previous studies
have shown that the cancer rates in US-born Asians approach that of non-Hispanic whites in
successive generations and that US-born Asians have distinct profiles from their foreign-born
counterparts (Reynolds et al., 2011; Gomez et al., 2010; Liu et al., 2012). The excess breast cancer
burden in Japanese Americans may also be partially attributed to higher mammogram usage, older
age at first childbirth, and lower number of childbirths compared to other Asian subgroups
(California Health Interview Survey, 2015), which are prevalent risk factors for breast cancer in
Western populations (Kelsey, Gammon, & John, 1993; Lambe et al., 1996). Premenopausal breast
cancer has unique protective factors such as weight status and breastfeeding. Further research is
needed to explain the higher breast cancer risk in premenopausal Japanese women.
Colorectal cancer rates were relatively high only among the Japanese subgroup, 25% and 11%
higher than those of non-Hispanic white men and women. This group also has been found to have
the highest colorectal cancer screening rate (83%) among Asian subgroups (California Health
Interview Survey, 2015). Because screening is known to reduce colorectal cancer incidence, our
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findings suggest that environmental factors are strong drivers of the colorectal cancer risk in this
group. As the only subgroup that is majority US-born (US Census, 2012b), the Japanese are more
likely to have adopted a Western lifestyle, including dietary habits and consequent obesity, which
is associated with increased risk for colorectal cancer (California Health Interview Survey, 2015;
Gingras & Béliveau, 2011). Similarly, in Japan, an increase in dietary intake of milk, meat, eggs,
and fat from 1950 to 1970 has been met with a concomitant sharp rise in colorectal cancer since
the early 1990s (Kuriki & Tajima, 2006). In most Asian countries, rapid economic growth resulted
in a shift from traditional dietary patterns to an increased intake of fat, sugar and animal-source
foods which leads to greater risk of colorectal cancer.
Lung cancer rates were highest among the Vietnamese subgroup, but still 11% and 47% lower
than those of non-Hispanic white men and women, respectively. Lung cancer rates are
predominantly a reflection of past smoking trends, and smoking prevalence is relatively low
among Asian Americans, particularly women. According to the California Health Interview
Survey, Vietnamese in California currently have the highest smoking rates among all Asian
subgroups while South Asians have the lowest. This coincides with our findings of higher rates for
Vietnamese and remarkably low lung cancer incidence among South Asians.
Stomach cancer rates were high among Koreans, Chinese, Japanese, and Vietnamese. Koreans
had the highest rates, nearly five times higher than non-Hispanic whites. The high risk for Koreans
compared to other countries in Asia is confirmed by global incidence rates provided by
GLOBOCAN (Ferlay et al., 2012). The primary identified cause of non-cardia stomach cancer is
infection with Helicobacter pylori. Interestingly, stomach cancer rates in South Asian and Filipino
subpopulations were similar to non-Hispanic whites despite a high prevalence of adult H. pylori
infection in their countries of origin (Destura et al., 2004; World Gastroenterology Organization,
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2010). The extremely high vulnerability observed in Korean and other Asian subgroups could be
related to a high dietary salt intake, which may enhance H. pylori colonization, alter gastric mucus
viscosity, or damage gastric epithelium, all of which facilitate the development of stomach cancer
(Kim, 2003; Wang, Terry, & Yan, 2009).
Liver cancer rates were higher than those of non-Hispanic whites in all Asian subgroups except
South Asian men. The highest rates, almost five times higher, were observed in the Vietnamese
subpopulation. Infection with hepatitis B virus (HBV) is the major cause of liver cancer in Asia
and developing countries, while in the US, hepatitis C virus (HCV) is the more common viral
cause. Nonetheless, the Vietnamese American population has a high prevalence, 14%, of chronic
HBV infection (Nguyen & Keeffe, 2003), which may partially be attributed to the absence of
newborn hepatitis B vaccination in Vietnam until 2012 (Nguyen, Law, & Dore, 2008). Moreover,
the 6% prevalence of HCV infection in Vietnam is high compared to the average prevalence of 2%
for most other Asian countries (Nguyen & Keeffe, 2003). These trends may account for the
observed high rates among Vietnamese in our study. In general, populations in Asia have a higher
risk of liver cancer because they tend to acquire HBV and HCV infection at a young age (Nguyen
& Keeffe, 2003). South Asians in our study have relatively low liver cancer incidence, which may
be attributed to a lower prevalence of both HBV (3%) and HCV (1%-1.5%) infections in South
Asia compared to other countries in East and Southeast Asia (Puri, 2014; Dhiman, 2014). Notably,
the predominant mode of transmission of HBV and HCV in India is blood transfusion and the use
of unsafe therapeutic injection rather than the usual vertical transmission at the time of birth, most
common in Asia (Tandon, Acharya, & Tandon, 1996; Mukhopadhya, 2008). There are several
other risk factors associated with liver cancer, such as alcohol use, smoking, and obesity. However,
given the lower prevalence of binge drinking, smoking, and obesity among Asian Americans
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(California Health Interview Survey, 2015), viral infection is the most likely cause for the heavy
burden of liver cancer in specific Asian subgroups. Since liver cancer has a poor prognosis, more
action to screen for and prevent the progression of hepatitis B and C among certain Asian
subgroups, especially the Vietnamese, is warranted.
Nasopharyngeal cancer rates were strikingly high among Chinese, Vietnamese, and Filipino
subgroups. The highest rates, observed in Chinese, were more than 13 times higher than those of
non-Hispanic whites. Infection with Epstein-Barr virus (EBV) is associated with undifferentiated
nasopharyngeal carcinoma (Thompson & Kurzrock, 2004). Previous research indicates that the
unusual high risk for nasopharyngeal cancer in certain Asian subgroups may be attributed to
genetic predisposition and environmental factors that alter the oncogenic properties of EBV as
well as increase susceptibility to environmental carcinogens (Li, Fasano, Wang, Yao, & Marincola,
2009; Chang & Adami, 2006). When adjusted to the World Standard, the rates in our study for the
Chinese subgroup (6.8/100,000 in men and 2.2/100,000 in women) were actually higher than those
reported by GLOBOCAN for China (2.7/100,000 in men and 1.1/100,000 in women) (Ferlay et
al., 2012). The first generation of Chinese Americans came mainly from China’s Guangdong
Province where nasopharyngeal carcinoma rates are much higher than in other provinces (Cao,
Simons, & Qian, 2011). Moreover, nasopharyngeal cancer is known to occur with obvious familial
aggregation (Cao et al., 2011). These patterns may contribute to our observed elevated rates. In
any case, further studies on nasopharyngeal carcinoma in Asian subgroups should be conducted to
clarify this increased risk.
Cervical cancer rates were high in the Vietnamese subgroup only. This finding is baffling given
prior studies showing Vietnamese women with the highest cervical screening test (Pap) usage (76%
in 2007) among all Asian subgroups (California Health Interview Survey, 2015). Low English
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proficiency, low educational attachment, and high poverty rates among Vietnamese women may
adversely impact their receipt of assistance with cervical cancer control (Taylor, Nguyen, Jackson,
& McPhee, 2008; California Health Interview Survey, 2015). We could not find any literature on
the prevalence of HPV infection and its oncotypes among the Vietnamese subgroup.
Thyroid cancer rates were relatively high among Filipinos compared to other Asian subgroups
and non- Hispanic whites, although the reasons are unclear. Risk factors include a history of goiter
or thyroid nodules and lower soy isoflavone consumption (Haselkorn, Stewart, & Horn-Ross,
2003). Due to early clinical detection and diagnosis, multiple countries including the US have
experienced a substantial increase in thyroid cancer incidence without a concomitant increase in
mortality (Ahn, Kim, & Welch, 2014; Haselkorn et al., 2015). While Filipinos have a higher
healthcare access rate and lower poverty rate than other Asian subgroups (California Health
Interview Survey, 2015), it is unlikely that increased detection alone would explain this higher risk
for thyroid cancer.
The role of acculturation in explaining some of the variability in our observed results cannot
be directly measured. However, it is worth noting that the Japanese, who have the longest history
in the US, seem to have intermediate rates between those of other Asian subgroups and nonHispanic whites for prostate, breast, and uterine cancer. Their colorectal cancer rates actually
surpass those of non-Hispanic whites in our study. These cancers are often associated with a
Western lifestyle. Yet the rates for liver and stomach cancer for the Japanese subgroup remain
higher than those of non-Hispanic whites. This suggests that the process of cancer risk conversion
from culture of origin to the dominant culture is complex and spans more than one generation. To
a lesser extent, the Filipino subgroup also shows a pattern consistent conversion in cancer risk due
to acculturation. South Asians seem to be the most distinct of all subgroups and show overall the
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lowest risk for cancer among men, with remarkably low rates of lung and colorectal cancers. Aside
from a low smoking rate and dominant vegetarian diet (California Health Interview Survey, 2015;
Mohandas, 2011), the causes of this apparent lack of vulnerability, especially for colorectal cancer,
are worth further study.
Overall, these results complement previously published research (Gomez et al., 2013; Miller
et al., 2008; McCracken et al., 2007). In the most recent publication on this subject, Gomez et al.
(2013) reported incidence rates by Asian subgroup for five of the most common cancer sites for
the period 2004-2008. Our rates for 2009-2011 are not dissimilar after taking into account the
decreasing trends for cancer incidence in Asian men and the stable trends in Asian women reported
in the most recent Annual Report on Cancer (Kohler et al., 2015).
A significant strength of this study is that it provides rates for the largest coverage to date of
Asian Americans, more than two thirds of the overall total national Asian population, by using
cancer registry data from both SEER and NPCR. Out of the total US Asian population of 14.7
million, 73% of Chinese, 79% of Filipino, 78% of Japanese, 65% of Korean, 63% of South Asian,
and 65% of Vietnamese American populations were covered. The inclusion of the NPCR data in
our study increased the coverage of all Asian subgroups, especially South Asians, whose coverage
was doubled. An additional strength is our application of an equitable and unbiased method to
impute Asian NOS cases, which accounted for 15% of Asian cancer cases. We address the
specificities of NAACCR data collection on Asians with new methodology building on previous
work by Pinheiro et al. (2009). By accounting for NOS cases, the overall rates are approximately
5%-6% higher than those based on the current race descriptors and algorithm. However, the
increment varies considerably by cancer site, and is as high as 9% for cancers with better prognosis,
such as thyroid, breast, and prostate cancers. In summary, this study is the first to provide incidence
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rates that are directly comparable among specific Asian subgroups as well as between them and
other US reference populations.
NAACCR designed the NAACCR Asian/Pacific Islander Identification Algorithm (NAPIIA)
to reduce Asian NOS cases (North American Association of Central Cancer Registries, 2016b).
NAPIIA uses name and birthplace to enhance the race identification among Asian NOS cases
indirectly. However, its use in this study would have introduced bias in the allocation of Asian
NOS cases because the coverage of the name and surname portion of the algorithm is not uniform
across major specified Asian subgroups and is absent among OSA subgroups. In practice, its use
in this study would have substantially overestimated Chinese cancer rates and underestimated
South Asian rates (data not shown).
Several limitations may have affected our results. The estimates assume that NOS cases occur
randomly across all Asian subgroups who share the same sex, cancer site, age group, and
geographic region. While this is the most logical assumption, it is possible that the reality may be
somewhat different. The precision of our confidence intervals may be overestimated because our
imputation model does not account for the uncertainty of the observed NOS counts. Another
possible limitation is that race/ethnicity data from cancer registries are derived from medical
records and administrative information while data from the Census are based on selfidentifications alone. The two may not be totally comparable. Also, birthplace was used to improve
identification of specified Asians and estimate OSAs, but the availability of birthplace data may
not be uniform across Asian subgroups. Finally, due to limited access to Race 2 data, estimates in
Florida were strictly based on Race 1. However, given the comparatively low number of Asian
cases in Florida, it is unlikely that this affected our results.
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This study portrays unique cancer incidence patterns among specific Asian subgroups and
provides a reliable baseline for future cancer surveillance research and health policy. Complex
phenomena like acculturation and cancer risk conversion may help explain why rates for certain
cancers remain higher than average among Asian Americans while cancer risk for the leading four
cancers appears to be converging with US averages (Liu et al., 2012; Lee, Chen, Jung, BaezcondeGarbanati, & Juon, 2014). Nonetheless, these analyses on the heterogeneity of cancer profiles
among Asian subgroups can provide unique opportunities to better understand the epidemiology
of these cancers as well as facilitate future research hypotheses. The variations observed require
future research to explore cancer susceptibility among Asian American subgroups. In addition,
this study highlights the critical importance of public health efforts that target cancer disparities
among Asian subgroups through improved surveillance and prevention efforts, including
screening and community-based education.
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Chapter 4
Stomach Cancer Survival among US Asian American Populations
Introduction
Stomach cancer is the third leading cause of cancer death and the fifth most common cancer
worldwide, with some of the highest incidence and mortality rates found in the Eastern Asian
countries of China, Japan, and Korea (International Agency for Research on Cancer, 2016). In the
United States (US), the fastest growing minority population is Asian American, due to an
immigration surge from these and other Asian countries, including India, Vietnam, and Philippines
(US Census, 2012a). Not surprisingly, this ongoing demographic shift is impacting the stomach
cancer profile in the US (International Agency for Research on Cancer, 2016). While overall
stomach cancer incidence and mortality rates have decreased steadily in the past two decades,
survival remains relatively low compared to other cancers, at least in part due to a high proportion
of diagnoses at an advanced stage (Howlader et al., 2015).
Compared to non-Hispanic whites, Asian Americans, as a whole, have higher stomach cancer
incidence, but also have better survival outcomes (Jin, Pinheiro, Xu, & Amei, 2015; Gomez et al.,
2013; Wang, Sun, & Bertagnolli, 2015; Bonenkamp et al., 1993; Strong et al., 2010; Davis & Sano,
2001; Theuer, Kurosaki, Ziogas, Butler, & Anton-Culver, 2000; Nelson et al., 2013; Howard, Hiles,
Leung, Stern, & Bilchik, 2015; Theuer, 2000; Gill, Shah, Le, Cook, & Yoshida, 2003; Kim et al.,
2009; Merchant, Li, & Kim, 2014; Schwarz & Zagala-Nevarez, 2002; Kim et al., 2009). Previous
research, while not conclusive, has linked the survival advantage of Asian Americans to tumors at
a more distal anatomic site, diagnosis at earlier tumor stages, diagnosis at younger ages, and more
aggressive treatment approaches (Wang, Sun, & Bertagnolli, 2015; Bonenkamp et al., 1993;
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Strong et al., 2010; Davis & Sano, 2001; Theuer, Kurosaki, Ziogas, Butler, & Anton-Culver, 2000;
Nelson et al., 2013; Howard, Hiles, Leung, Stern, & Bilchik, 2015; Theuer, 2000; Gill, Shah, Le,
Cook, & Yoshida, 2003; Kim et al., 2009; Merchant, Li, & Kim, 2014; Schwarz & Zagala-Nevarez,
2002; Kim et al., 2009). Identifying the causes of survival disparities between racial and ethnic
groups has the potential to shed light on prognostic factors as well as protective attributes, and
inform public health professionals tasked with reducing those disparities while improving cancer
outcomes for all populations.
Most cancer research to date has treated the Asian American population in the aggregate
(Gomez et al., 2014). However, this population is heterogeneous, not only genetically, but also
with respect to lifestyle, culture, immigration and settlement experiences (Pew Research Center,
2013). Aggregation of all Asians in epidemiological research ignores potential Asian subgroup
variation in critical factors that impact cancer survival, including sociodemographic factors, tumor
characteristics, healthcare access and quality, and cancer coping mechanisms (Gomez et al., 2014).
Cancer survival patterns may differ between Asian subgroups in the US as well as between these
subgroups and non-Hispanic whites. In order to elucidate the true factors responsible for stomach
cancer survival disparities, with the ultimate aim of improving outcomes for all Americans, it is
important to carefully characterize these subgroup differences for comparison with each other as
well as the majority non-Hispanic white population.
In the current study, we use the Surveillance, Epidemiology, and End Results (SEER) Program
data from 2000 through 2012 to calculate 5-year stomach cancer survival estimates for nonHispanic whites and the six largest Asian subgroups in the US: Chinese, Filipino, Japanese, Korean,
South Asian, and Vietnamese. Survival differences between these subgroups as well as in
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comparison to non-Hispanic whites were examined after adjustment for the known important
prognostic factors in stomach cancer survival.
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Material and Methods
Study Purpose
The purpose of this study is to investigate stomach cancer survival disparities among Asian
Americans in the US.
Research Question
Do stomach cancer survival disparities exist among specific Asian subgroups?
Hypotheses
Hypothesis 1
H0: Age-adjusted overall stomach cancer 5-year survival do not vary between nonHispanic whites and Asians from 2000 to 2012
HA: Age-adjusted overall stomach cancer 5-year survival vary between non-Hispanic
whites and Asians from 2000 to 2012
Hypothesis 2
H0: Age-adjusted overall stomach cancer 5-year survival do not vary between Asian
subgroups from 2000 to 2012
HA: Age-adjusted overall stomach cancer 5-year survival vary between Asian subgroups
from 2000 to 2012
Hypothesis 3
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H0: Age-adjusted stage-specific stomach cancer 5-year survival do not vary between nonHispanic whites and Asians from 2000 to 2012
HA: Age-adjusted stage-specific stomach cancer 5-year survival vary between nonHispanic whites and Asians from 2000 to 2012
Hypothesis 4
H0: Age-adjusted stage-specific stomach cancer 5-year survival do not vary between
Asian subgroups from 2000 to 2012
HA: Age-adjusted stage-specific stomach cancer 5-year survival vary between Asian
subgroups from 2000 to 2012
Hypothesis 5
H0: Age-adjusted subsite-specific stomach cancer 5-year survival do not vary between
non-Hispanic whites and Asians from 2000 to 2012
HA: Age-adjusted subsite-specific stomach cancer 5-year survival vary between nonHispanic whites and Asians from 2000 to 2012
Hypothesis 6
H0: Age-adjusted subsite-specific stomach cancer 5-year survival do not vary between
Asian subgroups from 2000 to 2012
HA: Age-adjusted subsite-specific stomach cancer 5-year survival vary between Asian
subgroups from 2000 to 2012
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Hypothesis 7
H0: Race/ethnicity predicts stomach cancer survival after adjusting for important
prognostic factors.
HA: Race/ethnicity does not predict stomach cancer survival after adjusting for important
prognostic factors.
HA1: Asian race predicts better stomach cancer survival than non-Hispanic whites
after adjusting for important prognostic factors.
HA2: Specific Asian ethnicity predicts better stomach cancer survival than nonHispanic whites after adjusting for important prognostic factors.
Study Population and Covariates
Population-based cancer data for non-Hispanic whites and Asians (regardless of Hispanic
ethnicity) aged 15 years or older were obtained from the SEER 18 registries, which cover 25% of
the white and 50% of the Asian American population in the US (Surveillance, Epidemiology, and
End Results Program, 2010). Cases selected for analysis had an invasive tumor of the stomach
diagnosed during the 13-year period from January 1, 2000 through December 31, 2012. Excluded
cases were younger than 15 years old, diagnosed only at death or during autopsy, and those with a
second or subsequent malignancy.
Net survival was calculated using a cause-specific survival framework, based on the SEER
classification of cause-specific death (Howlader et al., 2010). Using the reported alive method,
survival time was calculated in months from the date of diagnosis to whichever occurred first: the
date of death from stomach cancer, the date of last alive follow-up, or the final date of the study
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period, December 31, 2012. Those with zero survival time were excluded; cases were censored at
date lost to follow up or date of death from other causes. We censored all cases at a cutoff of 60
months for survival analysis.
Eleven specific Asian subgroups are coded in the North American Association of Central
Cancer Registries (NAACCR) standards: Asian Indian, Chinese, Filipino, Hmong, Japanese,
Kampuchean, Korean, Laotian, Pakistani, Thai, and Vietnamese (NAACCR, 2015). The
NAACCR Asian/Pacific Islander Identification Algorithm (NAPIIA) enhances the identification
of Asian subgroup status by using name and birthplace information (Hsieh, Pareti, & Chen, 2011).
We aggregated Asian Indian and Pakistani into one single category, South Asian, because the
NAACCR protocol did not code them separately until 2010 (NAACCR, 2015), and examined the
6 largest US Asian subgroups, hereafter referred to as Asian ethnicities: Chinese, Filipino,
Japanese, Korean, South Asian, and Vietnamese. Smaller Hmong, Kampuchean, Laotian, and Thai
populations as well as Asian cases with unknown ethnicity were combined into a single Other
Asian category; however, they are not included in the survival analyses.
Other sociodemographic variables assessed for impact on survival were sex, age, marital status,
insurance status, and socioeconomic status (SES). International age standard survival classification
categories were used to form 5 age groups: 15-44, 45-54, 55-64, 65-74, and 75+ (Corazziari, Quinn,
& Capocaccia, 2004]. Insurance status was grouped into 4 mutually exclusive groups: insured,
which

included

Medicare

and

private

insurance;

Medicaid,

including

dual-eligible

Medicaid/Medicare cases; uninsured; and unknown. Data on socioeconomic status (SES),
reflecting aspects of social stratification that play a critical role in cancer survival, are not routinely
collected at the individual level by cancer registries. Using census tract information on cases, we
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adopted a quintile SES index that has been shown to detect socioeconomic gradients in cancer
survival (Yu, Tatalovich, Gibson, & Cronin, 2014)
Routinely collected clinical data for each stomach cancer case, including primary anatomic
site, histology, grade, and staging, were coded and reported according to the International
Classification of Diseases for Oncology, Third Edition (ICD-O-3). Anatomic site was divided into
four sublocations: cardia (C16.0); middle, comprising fundus, body, or curvatures (C16.1, C16.2,
C16.5, and C16.6); distal, including antrum or pylorus (C16.2 and C16.3); and overlapping or not
otherwise specified (NOS) (C16.8 and C16.9). Histological types were categorized according to
the Lauren’s classification and previous studies (Lauren, 1965; Pinheiro, van der Heijden, &
Coebergh, 1999) into either diffuse type (codes 8020-8022, 8142, 8145, and 8490), intestinal type
(8140, 8144, 8210-8211, 8260, and 8480- 8481), NOS (8000-8010), or other. Additional clinical
covariates included SEER stage at diagnosis (localized, regional, distant, and unknown), tumor
grade (I-IV and unknown), and treatment modality (surgery and radiation).
Statistical Analyses
Sociodemographic and clinical characteristics by race and Asian ethnicity were summarized
with descriptive statistics. Five-year age-standardized overall survival, as well as survival stratified
by anatomic site and stage at diagnosis, was calculated using the life table method (Corazziari,
Quinn, & Capocaccia, 2004).
Univariate analyses to determine significant prognostic factors were performed using the logrank test, and covariates were tested for interaction effects. Multivariate survival analyses using
Cox proportional hazards regression models produced hazard ratios (HRs) and corresponding 95%
confidence intervals (CIs) for risk of stomach cancer-specific mortality. The proportional hazards
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assumption, assessed by visual inspection of the log (-log) plot of the survival distribution for each
independent variable, had no significant violations. Variables were included via forward stepwise
selection to assess the relative impact of significant prognostic factors.
Curative and palliative surgical treatments cannot be differentiated by cancer registry data.
However, the goals of surgical management of stomach cancer largely depend on the stage at
diagnosis. In order to assess the factors affecting receipt of curative-intent surgery, we assumed
that surgeries in patients with localized stomach cancer are curative-intent. Multivariate stepwise
logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for
receipt of curative-intent surgery.
All statistical tests were 2-sided with a significance level of 0.05. All analyses were performed
with SAS 9.3.
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Results
A total of 33,313 non-Hispanic white and 8,473 Asian stomach cancer cases were studied. The
distribution of Asians by ethnic group was as follows: 24% Korean, 24% Chinese, 21% Japanese,
12% Filipino, 10% Vietnamese, 5% South Asian, and 5% other Asian. Sociodemographic and
clinical characteristics varied significantly between Asians and non-Hispanic whites, as well as
between Asian ethnicities.
Table 17. Sociodemographic characteristics by race and Asian ethnicity in patients with stomach cancer, 2000-2012*
South
Other
Chinese
Filipino Japanese
Korean
Vietnamese
Total Asian
Asian
Asian
(N=2022)
(N=990) (N=1739) (N=2034)
(N=416)
(N=866)
(N=406) (N=8473)
Characteristic
N
%
N
%
N
%
N
%
N
%
N
%
N
%
N %
Sex
Male
1153 57.0 506 51.1 932 53.6 1178 57.9 254 61.1 515 59.5 223 54.9 4761 56.2
Female
869 43.0 484 48.9 807 46.4 856 42.1 162 38.9 351 40.5 183 45.1 3712 43.8
Age at diagnosis
15-44
142 7.0
74 7.5
37 2.1 154 7.6
75 18.0
87 10.0
60 14.8
629 7.4
45-54
223 11.0 121 12.2 116 6.7 300 14.7
82 19.7 138 15.9
59 14.5 1039 12.3
55-64
341 16.9 214 21.6 215 12.4 439 21.6
95 22.8 176 20.3
89 21.9 1569 18.5
65-74
502 24.8 245 24.7 426 24.5 625 30.7
85 20.4 211 24.4
97 23.9 2191 25.9
75+
814 40.3 336 33.9 945 54.3 516 25.4
79 19.0 254 29.3 101 24.9 3045 35.9
Marital status
Never married
161 8.0
71 7.2 169 9.7 173 8.5
31 7.5
91 10.5
50 12.3
746 8.8
Married
1399 69.2 638 64.4 1061 61.0 1412 69.4 300 72.1 588 67.9 251 61.8 5649 66.7
Previously married 394 19.5 249 25.2 456 26.2 368 18.1
62 14.9 149 17.2
90 22.2 1768 20.9
Unknown
68 3.4
32 3.2
53 3.0
81 4.0
23 5.5
38 4.4
15 3.7
310 3.7
Insurance status
Uninsured
50 2.5
28 2.8
12 0.7 106 5.2
29 7.0
20 2.3
14 3.4
259 3.1
Any Medicaid
408 20.2 122 12.3
29 1.7 314 15.4
59 14.2 226 26.1
86 21.2 1244 14.7
Insured
1004 49.7 473 47.8 805 46.3 730 35.9 233 56.0 320 37.0 168 41.4 3733 44.1
Unknown
560 27.7 367 37.1 893 51.4 884 43.5
95 22.8 300 34.6 138 34.0 3237 38.2
SES, quintile
1 (lowest)
250 12.4 103 10.4 115 6.6 323 15.9
32 7.7 145 16.7 110 27.1 1078 12.7
2
227 11.2 162 16.4 249 14.3 292 14.4
37 8.9 189 21.8
68 16.7 1224 14.4
3
318 15.7 229 23.1 376 21.6 291 14.3
54 13.0 215 24.8
66 16.3 1549 18.3
4
458 22.7 259 26.2 450 25.9 440 21.6 107 25.7 171 19.7
70 17.2 1955 23.1
5
739 36.5 229 23.1 536 30.8 610 30.0 180 43.3 141 16.3
88 21.7 2523 29.8
Unknown
30 1.5
8 0.8
13 0.7
78 3.8
6 1.4
5 0.6
4 1.0
144 1.7
*
Totals may not equal 100% due to rounding.

NH white
(N=33313)
N %
21257 63.8
12056 36.2
1631
3996
7015
8434
12237

4.9
12.0
21.1
25.3
36.7

3437
19491
8811
1574

10.3
58.5
26.4
4.7

959
1759
19097
11498

2.9
5.3
57.3
34.5

4465
6290
7055
7545
7468
490

13.4
18.9
21.2
22.6
22.4
1.5

In both races and every Asian ethnic group, cases were more likely to be male than female: the
widest difference was seen in non-Hispanic whites, 64% male and 36% female; the narrowest in
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Filipinos, at 51% male and 49% female. Age at diagnosis distributions differed significantly, with
a much higher proportion of South Asians (38%) diagnosed younger than 55 years of age than
non-Hispanic whites (17%) or any other Asian ethnicity. Conversely, Japanese cases had almost
80% of cases diagnosed at ages older than 65, higher than all other comparison groups, including
non-Hispanic whites at 62% and Koreans at 56% (Table 17)
Table 18. Clinical characteristics by race in patients with stomach cancer, 2000-2012*
South
Chinese
Filipino Japanese
Korean
Vietnamese
Asian
(N=2022)
(N=990) (N=1739) (N=2034)
(N=416)
(N=866)
Characteristic
N
%
N
%
N
%
N
%
N
%
N
%
Year of diagnosis
2000-2003
579 28.6 273 27.6 630 36.2 574 28.2
97 23.3 233 26.3
2004-2007
610 30.2 317 32.0 538 30.9 679 33.4 126 30.3 298 33.6
2008-2012
833 41.2 400 40.4 571 32.8 781 38.4 193 46.4 355 40.1
Stage at diagnosis
Localized
552 27.3 268 27.1 523 30.1 701 34.5 127 30.5 197 22.7
Regional
684 33.8 289 29.2 544 31.3 655 32.2 110 26.4 296 34.2
Distant
585 28.9 349 35.3 534 30.7 518 25.5 134 32.2 305 35.2
Unknown
201 9.9
84 8.5 138 7.9 160 7.9
45 10.8
68 7.9
Anatomic site
Cardia
222 11.0 192 19.4 230 13.2
99 4.9
93 22.4
75 8.7
Middle
601 29.7 299 30.2 567 32.6 684 33.6 121 29.1 255 29.4
Distal
736 36.4 242 24.4 531 30.5 780 38.3
90 21.6 330 38.1
Overlapping/NOS
463 22.9 257 26.0 411 23.6 471 23.2 112 26.9 206 23.8
Histology
Intestinal
1226 60.6 523 52.8 1098 63.1 1263 62.1 198 47.6 517 59.7
Diffuse
521 25.8 274 27.7 414 23.8 561 27.6 105 25.2 247 28.5
NOS
84 4.2
32 3.2
52 3.0
78 3.8
9 2.2
29 3.3
Other
191 9.4 161 16.3 175 10.1 132 6.5 104 25.0
73 8.4
Grade
I
75 3.7
32 3.2
94 5.4
76 3.7
28 6.7
28 3.2
II
376 18.6 194 19.6 406 23.3 427 21.0
74 17.8 173 20.0
III
1157 57.2 540 54.5 991 57.0 1222 60.1 192 46.2 508 58.7
IV
44 2.2
21 2.1
30 1.7
23 1.1
6 1.4
16 1.8
Unknown
370 18.3 203 20.5 218 12.5 286 14.1 116 27.9 141 16.3
Surgery
Yes
1263 62.5 536 54.1 1061 61.0 1399 68.8 228 54.8 522 60.3
No
756 37.4 449 45.4 661 38.0 630 31.0 184 44.2 343 39.6
Unknown
3 0.1
5 0.5
17 1.0
5 0.2
4 1.0
1 0.1
Radiation
Yes
458 22.7 235 23.7 373 21.4 410 20.2 101 24.3 193 22.3
No
1543 76.3 742 74.9 1329 76.4 1600 78.7 304 73.1 657 75.9
Unknown
21 1.0
13 1.3
37 2.1
24 1.2
11 2.6
16 1.8
*
Totals may not equal 100% because of rounding
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Other
Total Asian
Asian
(N=406) (N=8473)
N
%
N %

NH white
(N=33313)
N %

97 23.9
116 28.6
193 47.5

2478 29.2 10607 31.8
2677 31.6 10198 30.6
3318 39.2 12508 37.5

114
110
133
49

28.1
27.1
32.8
12.1

2482
2688
2558
745

29.3 9429 28.3
31.7 8776 26.3
30.2 11661 35.0
8.8 3447 10.3

40 9.9
115 28.3
140 34.5
111 27.3

951
2642
2849
2031

11.2 13245 39.8
31.2 7468 22.4
33.6 5165 15.5
24.0 7435 22.3

228 56.2
107 26.4
20 4.9
51 12.6

5053
2229
304
887

59.6 20814 62.5
26.3 6255 18.8
3.6 1404 4.2
10.5 4840 14.5

13 3.2
68 16.7
234 57.6
10 2.5
81 20.0

346
1718
4844
150
1415

4.1 1701 5.1
20.3 7169 21.5
57.2 15849 47.6
1.8
763 2.3
16.7 7831 23.5

215 53.0
190 46.8
1 0.2

5224 61.7 16164 48.5
3213 37.9 16882 50.7
36 0.4
267 0.8

66 16.3
333 82.0
7 1.7

1836 21.7 8319 25.0
6508 76.8 24296 72.9
129 1.5
698 2.1

The greatest variations were observed in gastric tumor characteristics. Non-Hispanic whites
had a 3.5 times higher proportion of cardia tumors than Asians in the aggregate, but nearly 8 times
higher than the largest Asian ethnic group in our study, Koreans. Most Asian ethnicities had a
similar proportion as non-Hispanic whites of tumors diagnosed at the localized stage,
approximately 28%, but Koreans had a larger share (35%) and Vietnamese had much lower (23%),
resulting in a 1.5-fold difference between these two groups (Table 18).
Every Asian ethnic group had a significantly more favorable 5-year survival proportion than
non-Hispanic whites, who had the lowest, at 29.8% (Table 19). Among Asians, Koreans had the
highest survival at 45.4%. Vietnamese and Filipinos were relatively low, at 35.7% and 36.4%
respectively. After stratification by anatomic site, survival patterns in the Asian ethnic groups
altered considerably, although non-Hispanic whites retained significantly lower survival rates at
every anatomic site. Chinese, South Asians, and Koreans showed the best survival for cardia,
middle, and distal stomach cancer, respectively. Similarly, after stratification by stage at diagnosis,
the survival advantage in Koreans only remained for localized stomach cancer, while Chinese and
Filipinos had highest survival in regional and distant stomach cancers, respectively. As with
anatomic site, non-Hispanic whites had worse survival than Asians for every stage of diagnosis.
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Table 19. Age-standardized 5-year survival by race and Asian ethnicity in patients with gastric cancer, 2000-2012*
Chinese
Filipino
Japanese
Korean
South Asian
Vietnamese
% (95% CI)
% (95% CI)
% (95% CI)
% (95% CI)
% (95% CI) % (95% CI)
Overall
42.2 (39.7-44.7) 36.4 (32.8-40.0) 38.6 (36.0-41.2) 45.4 (43.0-47.9) 43.4 (37.6-49.1) 35.7 (32.0-39.4)
Anatomic site
Cardia
37.1 (29.7-44.6) 28.6 (20.5-36.7) 28.4 (21.7-35.1) 35.0 (23.7-46.3) 25.1 (13.3-37.0) 17.8 (6.5-29.2)
Middle
51.5 (46.9-56.1) 43.8 (37.1-50.4) 49.8 (45.2-54.5) 51.9 (47.6-56.1) 54.7 (44.1-65.4) 47.3 (40.3-54.4)
Distal
44.2 (40.1-48.4) 37.1 (29.9-44.3) 43.0 (38.3-47.7) 53.9 (50.0-57.9) 46.8 (34.5-59.2) 39.7 (33.8-45.7)
Overlapping/NOS 28.8 (24.1-33.6) 32.6 (25.9-39.3) 27.2 (22.5-31.9) 25.7 (21.1-30.3) 40.8 (30.3-51.4) 20.6 (14.1-27.1)
Stage
Localized
77.7 (73.3-82.1) 71.1 (64.3-77.9) 77.6 (73.2-81.9) 83.7 (80.5-86.9) 76.8 (69.2-84.4) 72.9 (65.3-80.5)
Regional
44.7 (40.4-48.9) 39.0 (31.9-46.0) 41.7 (37.1-46.3) 41.1 (36.9-45.4) 36.7 (25.0-48.4) 41.2 (35.0-47.5)
Distant
9.0 (5.9-12.1) 10.7 (6.9-14.6)
7.7 (5.2-10.2)
6.5
(3.9-9.2)
7.2 (1.5-12.8) 9.2 (5.2-13.2)
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Other Asian
% (95% CI)

Total Asian
% (95% CI)

NH white
% (95% CI)

36.8 (31.2-42.4)

40.7 (39.5-41.9)

29.8 (29.2-30.3)

28.3
41.6
33.0
37.2

30.9
49.4
44.9
28.4

23.1
41.4
35.1
26.5

(10.3-46.3)
(30.5-52.7)
(23.4-42.7)
(27.6-46.7)

68.6 (58.5-78.8)
39.5 (28.5-50.5)
5.5 (0.0-11.0)

(27.3-34.4)
(47.2-51.6)
(42.8-47.0)
(26.1-30.6)

78.3 (76.3-80.3)
40.7 (38.6-42.9)
7.8
(6.5-9.1)

(22.3-24.0)
(40.1-42.6)
(33.7-36.6)
(25.3-27.6)

66.1 (65.0-67.2)
27.0 (25.9-28.1)
5.4
(4.9-5.9)

In univariate survival analyses, the following variables were significant predictors for stomach
cancer survival: sex, age at diagnosis, marital status, insurance status, SES, year of diagnosis,
cancer registry, stage at diagnosis, anatomic site, histology, grade, treatment by surgery and
treatment by radiation. Nonetheless, treatment modalities were not included in the multivariate
survival analyses primarily because they were largely dependent upon stage at diagnosis and
anatomic site, but also because cancer registry data does not differentiate between curative and
palliative treatments. Due to strong interaction with SES and a high proportion of unknowns,
insurance status was also not included. Similarly, grade was excluded due to a significant
interaction with stage at diagnosis.
Given the variations in 5-year survival by tumor characteristics, three separate models were
generated to examine their impacts on racial and ethnic group disparities (Table 20). After
adjusting for histology and other major prognostic variables (Model 1), Koreans showed
significantly better survival than non-Hispanic whites and every other Asian ethnic group.
Adjusting for anatomic site yielded the same, although attenuated results: all Asian groups as well
as non-Hispanic whites were at higher risk of death from stomach cancer when compared to
Koreans (Model 2). However, after taking into account stage at diagnosis, any survival disparity
between Asian ethnicities disappeared (Model 3). However, even after controlling for all
prognostic factors available in our study, non-Hispanic whites had a significant survival
disadvantage compared to all Asians: 33% more likely to die after stomach cancer diagnosis.
In addition to race, other prognostic factors that significantly predicted stomach cancer survival
were stage at diagnosis, which showed a 6.5-fold increment in risk of death from distant stage to
localized stage; histology, with diffuse type tumors predicting1.23 times increased risk of death
over intestinal type; and anatomic site, where cardia gastric tumors showed the worst survival, 16%
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increased risk over distal tumors. Additionally, the risk of death was 21% higher in the lowest SES
quartile than the highest, and mortality risk steadily decreased with increasing SES.
Table 20. Risk of death from gastric cancer by prognostic factor among Asian American and non-Hispanic white
patients, 2000-2012
Model 1*
Model 2†
Model 3‡
HR
(95% CI) p-value
HR
(95% CI)
p-value HR
(95% CI)
p-value
Race/ethnicity
Korean
Chinese
1.15 (1.05-1.26) <0.01
1.14
(1.04-1.24)
0.01
1.01
(0.92-1.11)
0.83
Japanese
1.26 (1.15-1.39) <0.01
1.23
(1.12-1.36)
<0.01
1.05
(0.95-1.16)
0.32
Filipino
1.38 (1.24-1.54) <0.01
1.33
(1.19-1.48)
<0.01
1.10
(0.99-1.23)
0.08
South Asian
1.29 (1.10-1.52) <0.01
1.24
(1.05-1.45)
0.01
1.06
(0.90-1.24)
0.48
Vietnamese
1.27 (1.14-1.42) <0.01
1.27
(1.14-1.42)
<0.01
1.07
(0.95-1.19)
0.25
Non-Hispanic white 1.70 (1.59-1.82) <0.01
1.58
(1.48-1.70)
<0.01
1.33
(1.24-1.43)
<0.01
SES, quintile
5 (highest)
4
1.06 (1.02-1.10) <0.01
1.06
(1.02-1.10)
<0.01
1.05
(1.02-1.09)
0.01
3
1.10 (1.06-1.14) <0.01
1.10
(1.06-1.14)
<0.01
1.12
(1.08-1.17)
<0.01
2
1.13 (1.09-1.18) <0.01
1.13
(1.09-1.18)
<0.01
1.16
(1.11-1.20)
<0.01
1
1.15 (1.10-1.21) <0.01
1.16
(1.11-1.21)
<0.01
1.21
(1.15-1.26)
<0.01
Unknown
1.02 (0.91-1.14)
0.74
1.02
(0.91-1.14)
0.74
1.05
(0.94-1.17)
0.40
Histology
Intestinal
Diffuse
1.28 (1.24-1.32) <0.01
1.28
(1.24-1.32)
<0.01
1.23
(1.19-1.27)
<0.01
NOS
1.60 (1.51-1.69) <0.01
1.41
(1.33-1.49)
<0.01
1.22
(1.15-1.30)
<0.01
Other
0.32 (0.30-0.34) <0.01
0.31
(0.30-0.33)
<0.01
0.41
(0.39-0.43)
<0.01
Anatomic site
Distal
Middle
1.05
(1.01-1.10)
0.01
1.01
(0.97-1.06)
0.54
Cardia
1.28
(1.23-1.33)
<0.01
1.16
(1.11-1.20)
<0.01
Overlapping/NOS
1.62
(1.56-1.69)
<0.01
1.30
(1.25-1.35)
<0.01
Stage at diagnosis
Localized
Regional
2.36
(2.26-2.46)
<0.01
Distant
6.49
(6.23-6.76)
<0.01
Unknown
3.37
(3.19-3.55)
<0.01
*
Model 1 was adjusted for race, sex, SES, age at diagnosis, marital status, year of diagnosis, cancer registry, and
histology
†
Model 2 was adjusted for model 1 variables plus anatomic site
‡
Model 3 was adjusted for model 2 variables plus stage at diagnosis

Among patients with localized stomach cancer, non-Hispanic whites had the lowest proportion
of receiving surgery at 70% while Koreans had the highest at 90% (Table 21). As a palliative
approach alone or a postoperative and intraoperative additional therapy, the overall radiation usage
was low, but still higher in non-Hispanic whites than Asian subgroups.
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Table 21. Surgery and radiation by race in patients with localized stomach cancer , 2000-2012*
South
Chinese
Filipino
Japanese
Korean
Vietnamese Other Asian Total Asian NH white
Asian
(n=552)
(n=268)
(n=523)
(n=701)
(n=127)
(n=197)
(n=114)
(n=2482) (n=9429)
Characteristic
%
%
%
%
%
%
%
%
%
Surgery
No
20.8
25.4
17.8
10.4
26.8
19.3
28.1
18.3
29.9
Yes
79.2
74.3
81.5
89.6
73.2
80.7
71.1
81.5
69.4
Unknown
0.4
0.8
0.9
0.2
0.7
Radiation
No
89.1
86.9
88.5
92.2
85.0
90.4
90.4
89.6
80.7
Yes
10.9
12.3
10.1
7.0
14.2
8.6
8.8
9.7
17.6
Unknown
0.7
1.3
0.9
0.8
1.0
0.9
0.8
1.7
*
Totals may not equal 100% because of rounding

Table 22. Odds ratios and 95% CIs for receipt of
curative-intent surgery among patients with localized
stomach cancer, 2000-2012*
Race
Non-Hispanic white
Chinese
Japanese
Filipino
Korean
South Asian
Vietnamese
SES, quintile
1 (lowest)
2
3
4
5
Unknown
Histology
Intestinal
Diffuse
NOS
Other
Anatomic site
Cardia
Middle
Distal
Overlapping/NOS

OR

(95% CI)

p-value

1.23
1.62
0.95
2.00
0.57
1.28

(0.97-1.56)
(1.22-2.15)
(0.70-1.29)
(1.52-2.62)
(0.38-0.88)
(0.87-1.87)

0.09
<0.01
0.73
<0.01
0.01
0.21

1.20
1.29
1.32
1.44
1.36

(1.03-1.40)
(1.11-1.49)
(1.13-1.53)
(1.23-1.68)
(0.93-1.99)

0.02
<0.01
<0.01
<0.01
0.11

0.72
0.38
1.58

(0.63-0.82)
(0.28-0.51)
(1.39-1.78)

<0.01
<0.01
<0.01

2.62
3.04
1.26

(2.32-2.96)
(2.66-3.48)
(1.10-1.43)

<0.01
<0.01
<0.01

*

Model was adjusted for race, SES, age at diagnosis, marital
status, year of diagnosis, cancer registry, histology, and
anatomic site

The odds of having curative-intent surgery in patients with localized stomach cancer varied
significantly by prognostic factor. Patients who were younger at diagnosis, having higher SES,
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currently married, and having tumors with less aggressive histological type and more distal
anatomic site were more likely to receive surgical treatment (Table 22). After adjusting for
potential confounders, Koreans and Japanese were 2 times and 1.6 times more likely to receive
surgery than non-Hispanic whites, respectively.

71

Discussion
The striking difference in stomach cancer survival between Asian and Western countries has
been the subject of much research (Gill et al., 2003; Kim et al., 2009; Merchant et al., 2014;
Bickenbach & Strong, 2012; Yamamoto, Rashid, & Wong, 2015). With the burgeoning Asian
American population in the US, SEER registries provides a unique platform to investigate this gap
by examining differences not only between non-Hispanic whites and Asians overall, but between
specific Asian ethnic groups within the same country. The results of our study showed that all of
the six largest Asian ethnicities in the US had significantly higher 5-year survival than nonHispanic whites. Koreans had substantially higher 5-year survival than other Asian groups,
especially Vietnamese. However, the disparate stomach cancer survival between Asian subgroups
could not be attributed to ethnicity alone; rather it is more likely stems from a different case mix
of important prognostic factors. Conversely, a persistent survival gap was observed between
Asians and non-Hispanic whites, even after adjustment for age, histology, sublocation of the tumor,
and other covariates. While sociodemographic factors such as younger age composition, better
insurance, and higher SES improved prognosis for stomach cancer survival, tumor characteristics
– notably, stage at diagnosis, histology, and anatomic site – were the most critical predictors,
attenuating and/or eliminating observed ethnic and racial differences.
Stage at diagnosis was the single strongest contributor to differential survival among stomach
cancer patients. Early tumor detection is critical to improve early stage diagnosis, but unfortunately
most early stage stomach cancer cases and even a large number of advanced cases are clinically
asymptomatic (Kim, Heo, Kim, Kim, & Kim, 2013). Nonetheless, the known poor prognosis for
distant-stage stomach cancer diagnoses has been the driver for increased efforts to detect tumors
before symptoms are manifest (Kim et al., 2013; Dan, So, & Yeoh, 2006; Yeh, Hur, Ward, Schrag
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& Goldie, 2015). For high-risk populations, research has shown that stomach cancer screening at
a rational interval is cost-effective (Dan et al., 2006; Yeh et al., 2015). However, given the
relatively low and still declining overall incidence and mortality rates, population-based screening
for stomach cancer is not currently recommended in the US. Thus, the utilization of stomach cancer
screening services is largely opportunistic, depending largely on individuals’ screening awareness
and willingness.
In contrast to the US, in response to high stomach cancer incidence, Japan and South Korea
have implemented free population-based stomach cancer screening since 1983 and 1999,
respectively, to increase early diagnosis and improve survival (Yoo, 2008; Mizoue et al., 2003).
In Japan, the current guideline recommends either an annual upper gastrointestinal barium X-ray
examination or an upper gastrointestinal endoscopy every two to three years for individuals older
than 50 years. The guidelines in Korea recommend upper gastrointestinal endoscopy every two
years for individuals aged 40 to 75 years (Hamashima, Kim, & Choi, 2015). In our study, stage at
diagnosis explains much of the Korean advantage in relation to other Asian ethnicities and to nonHispanic whites, as demonstrated by the model changes seen in Table 3. Overall, Koreans, who
are 79% foreign-born (Pew Research Center, 2013) show a favorable stage distribution compared
to all other groups. It is possible that due to the high stomach cancer incidence and accompanying
national public health strategy in Korea, stomach cancer screening awareness, likely consolidated
in native Koreans, is carried by Korean immigrants to the US. This may contribute to their
advantageous proportions of localized and distant stomach cancers, highest and lowest
respectively, compared to non-Hispanic whites and other Asian ethnic groups in the US. On the
other hand, since 68% of Japanese are US-born (Pew Research Center, 2013), their screening
awareness for stomach cancer is likely more similar to non-Hispanic whites, potentially explaining
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the less favorable stage distribution observed in this study, with proportions of localized tumors
that are no different from the Asian average or even that of non-Hispanic whites.
While stage at diagnosis greatly influences survival time, stomach cancer remains an
aggressive cancer for all stages, and is difficult to treat. Our study shows that a favorable stage
distribution is not the only source of the stomach cancer survival advantage in Asian Americans
because even in stratified analyses, non-Hispanic whites had lower 5-year survival in all stages.
Moreover, the Korean survival advantage over other Asian ethnicities only held for localized
stomach cancers; for distant stage diagnoses, Koreans were worse than other Asian groups and not
significantly better than non-Hispanic whites. Therefore, other tumor factors must also play a role
in explaining survival differences.
Stomach cancer demonstrates marked heterogeneity at the histological level. According to
Lauren’s classification, the two major histologic subtypes are intestinal type and diffuse type, and
these are associated with different survival expectancy (Lauren, 1965). Concurrent with previous
research, our study shows that cases with tumors of diffuse type have a significantly higher risk of
death than those with the more common intestinal type (Kim et al., 2009; Pinheiro et al., 1999).
Diffuse type, more common in females and young individuals, is characterized by the presence of
poorly differentiated tumor cells (Hu et al., 2012; Yang et al., 2011). Given a higher male to female
sex ratio and older age composition observed in non-Hispanic whites, they had a lower proportion
of diffuse type histology than Asians, as expected. In our study, the distribution of histological
subtypes was similar across all Asian ethnicities; Filipinos and South Asians had a lower
proportion of the favorable intestinal type histology and Vietnamese had somewhat higher diffuse
types. However, histological characteristics alone are not sufficient to explain the ethnic and racial
survival differences observed.
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Tumor anatomic site, whose distribution varied considerably by race and Asian ethnicity, is a
major determinant of stomach cancer survival, as shown in this and previous studies (Kim et al.,
2009; Pinheiro et al., 1999). Anatomic site determines treatment options, which impact survival.
For stomach cancer, surgery is the only curative treatment option, and the extent of gastric
resection and margins largely depends on the location of the tumor. Tumors located in the distal
part of the stomach are commonly treated by subtotal gastrectomy and reconstruction of digestive
continuity. However, tumors located at the middle or proximal (cardia) of the stomach may require
total gastrectomy or esophagogastrectomy, if extended into a lower esophageal, which result in a
relatively worse prognosis (Dikken et al., 2012; Orditura et al., 2014; An et al., 2008; Maruyama,
Sasako, Kinoshita, Sano, & Katai, 1996). Previous studies have shown that patients from Western
countries have a significantly higher proportion of cardia tumors, while patients in Asia have a
higher proportion of non-cardia stomach cancer. This variation could be attributed to risk factor
prevalence in these different populations. A major risk factor for non-cardia stomach cancer is
Helicobacter pylori infection; obesity and gastroesophageal reflux are associated with cancer in
the cardia (Karimi, Islami, Anandasabapathy, Freedman, & Kamangar, 2014; Kamangar,
Sheikhattari, & Mohebtash, 2011; Lagergren, Bergström, Lindgren, & Nyrén, 1999)
Non-Hispanic whites in our study verily had a substantially higher proportion of cardia
stomach cancer than Asians, yet even after stratification by anatomic demarcation, 5-year survival
remained poor. Koreans had a remarkably low proportion of cardia stomach cancer, contributing
further to their overall advantage. However, the favorable overall 5-year survival for Koreans over
other Asian ethnicities was diminished after stratifying by anatomic site, only remaining
significantly better for distal stomach cancer.
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Asian race has been shown to be an independent prognostic factor for stomach cancer survival
in many studies (Wang, Sun, & Bertagnolli, 2015; Bonenkamp et al., 1993; Strong et al., 2010;
Davis & Sano, 2001; Theuer, Kurosaki, Ziogas, Butler, & Anton-Culver, 2000; Nelson et al., 2013;
Howard, Hiles, Leung, Stern, & Bilchik, 2015; Theuer, 2000; Gill, Shah, Le, Cook, & Yoshida,
2003; Kim et al., 2009; Merchant, Li, & Kim, 2014; Schwarz & Zagala-Nevarez, 2002). Here, we
bolster those findings, demonstrating with multivariate analyses that each of the six major Asian
ethnic groups has a survival advantage compared to non-Hispanic whites. Critically, we found that
the survival disparities between Asian ethnicities disappeared after controlling for major
prognostic factors. To our knowledge, only one previous population-based study assessed the
impact of specific Asian groups on stomach cancer survival. Kim et al., using Los Angeles County
data, found significant survival disparities: Koreans had the highest and Filipinos had lowest
stomach cancer survival (Kim et al., 2009). Using the most current national data available, we
found a significant stomach cancer survival disparity between non-Hispanic whites and Asian
Americans, but no significant differences within the Asian ethnic groups.
In a separate analysis, we analyzed receipt of surgery for localized stages, which are more
likely to have curative-intent, and found that non-Hispanic whites had a lower proportion of
surgery than Asians for each tumor anatomic site. However, in a survival model restricted to
localized stage stomach cancer, differences in receipt of surgery were not enough to explain the
disparities between Asians and non-Hispanic whites. In short, the causes of the survival
disadvantage for non-Hispanic whites remain elusive; at the least, they are not discernible based
on variables collected by SEER.
Several limitations may have affected our results. First, we used cause-specific death as our
outcome which may be impacted by cause of death misclassification on death certificates.
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Secondly, since Asians are more likely to have incomplete follow-up compared to non-Hispanic
whites and censoring across Asian ethnic groups is neither random nor even (Pinheiro, Morris, Liu,
Bungum, & Altekruse, 2014), it is possible that stomach cancer survival among Asians as a whole
and/or by subgroup is overestimated. Loss to follow up, which contributes to inflated survival
estimates, may occur due to the return of immigrants with serious illnesses to their countries of
origin to die, a phenomenon known as the salmon bias (Pinheiro et al., 2014; Razum, 2006).
However, studies thus far indicate that salmon bias has limited impact on Asian American survival,
likely due to travel being too distant and time-consuming for gravely ill individuals to undertake
(Acciai, Noah, & Firebaugh, 2015; Tendulkar et al., 2012). Lastly, comorbidities, such as obesity,
heart disease and diabetes, are critical risk factors impacting stomach cancer outcomes, and there
is heterogeneity in these comorbidities among Asian ethnic groups. For example, Filipinos have
the highest Asian obesity rate (California Health Interview Survey, 2015). However, we were
unable to control for comorbidities, as such data are not routinely collected by cancer registries.
This study characterizes the distinctive stomach cancer survival patterns among the six major
Asian ethnic groups in the US, and compares these patterns to non-Hispanic whites. While there
were observed survival differences between Asian ethnicities, these can largely be attributed to
differences in major prognostic factors, such as stage at diagnosis and anatomic site. Therefore
stomach cancer survival analyses should always control for these confounding factors, which vary
significantly across race and ethnicity.
In addition to the demographic and clinical characteristics studied here, cancer screening
awareness and coping mechanisms after cancer diagnosis have important and lasting effects on
cancer outcomes. Among immigrants, these are known to be associated with culture and length of
stay in the US (Glenn, Chawla, Surani, & Bastani, 2009; Hwang, 2013). Although the lack of
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survival disparities among Asian ethnicities does not provide enough clues to explain the survival
disadvantage of non-Hispanic whites, revealed ethnic group differences point to the need for
increased awareness among all Americans of stomach cancer screening and potential surgical
options once diagnosed. This study provided a unique opportunity to better understand the
epidemiology of stomach cancer survival at a national level, and can serve to generate future
research hypotheses. With the increase in high-risk foreign-born Asian populations in the US
reaching stomach cancer ages (US Census Bureau, 2012; Howlader et al., 2015) further public
health efforts will be required to identify their protective survival attributes and prevent risk
assimilation. Moreover, the vulnerability of non-Hispanic whites for stomach cancer mortality has
yet to be explained.
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Chapter 5
Conclusions and Recommendations for Further Study
Asian Americans are the most rapidly growing racial/ethnic group in the United States (US),
recently surpassing Hispanics in rates of population growth. The immigration flows of foreignborn populations from Asia countries significantly impact the cancer profile of the US. Disparities
in cancer incidence and survival among Asian Americans have been largely overlooked because
of lack of detailed Asian ethnicity information and stereotypes concerning positive health profiles.
However, by acknowledging and leveraging the heterogeneity in Asian Americans, we have a
unique opportunity to uncover potential group-specific cancer risk and prognostic factors and
advance cancer knowledge. Here, several suggestions shall be considered in further research on
cancer disparities among specific Asian subgroups.
1. Increase population coverage and representativeness
Neither the population growth nor the geographic distribution is even across specific Asian
subgroups. Between 2000 and 2010, the Asian Indian population grew the fastest, by 68%,
followed by the Filipino (45%), Vietnamese (42%), Chinese (40%), and Korean (39%) populations.
The Japanese population experienced the slowest growth of all Asian subgroups by 14% only.
Even though the top 8 states with the largest Asian populations were covered in our incidence
analyses, the fastest Asian American population growth occurred in states with relatively less
Asian Americans, such as Nevada, Arizona, and North Carolina. Also, the distribution of Asian
American populations varied across the US. Japanese (70%) and Filipinos (66 %) had the two
largest proportions that lived in the West. Large proportions of Chinese (49%), Vietnamese (49%)
and Koreans (44%) lived in the West as well. A much lower proportion of Asian Indians (25%)
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lived in the West compared to the other groups. Larger proportions of Vietnamese (32%), Asian
Indians (29 percent), and Koreans (24%) lived in the South. A greater proportion of Asian Indians
(30%), Chinese (26 %), and Koreans (21%) lived in the Northeast. The Midwest had the lowest
proportion of each Asian subgroup. Therefore, inclusion of cancer registry data from both SEER
and NPCR catchment areas is important to produce accurate cancer incidence and survival
estimates for specific Asian subgroups.
2. Improve identification of Asian subgroups
The proportion of NOS cases increased rapidly from 1% in 1990 to 15% in 2012 in SEER and
is even higher in NPCR. The exclusion of NOS cases underestimates cancer incidence for Asian
subgroups. Several methods have been developed to improve the identification of Asian subgroups
by reassigning NOS to a specific Asian subgroups, such as NAPIIA and the stratified imputation
proposed in our study. However, both methods heavily rely on a correct birthplace. Once a cancer
patient dies, his/her birthplace will be updated on death certificate. Findings from previous study
conducted by Gomez et al. (2004) indicated that accuracy of birthplace information on death
certificate is extremely high because the completion of socio-demographic items on death
certificate requires assistance from a next-of-kin or a significant other of the deceased. Notably,
the availability of birthplace data may not be uniform across Asian subgroups and may introduce
new bias in incidence analysis. More important, such methods should be used with caution in
survival analysis, because correction by birthplace will raise the proportion of the deceased only.
As a result, death cases will be over-represented and survival estimates will be underestimated.
Race/ethnicity data from cancer registries are derived from medical records and administrative
information. The ultimate way to diminish NOS cases is to raise the awareness in healthcare
providers of collecting additional information on Asian ethnicity when an Asian patient is admitted.
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Census allows respondents to report multiple races. For each specific Asian group, four
different scenarios are produced to enumerate population data: (1) Asian alone with only one
specific Asian group reported, (2) Asian alone with two or more specific Asian groups reported,
(3) Asian in combination with non-Asian race(s) with only one specific Asian group reported, and
(4) Asian in combination with non-Asian race(s) with two or more specific Asian groups reported.
To simplify Census’s 4-scenario method, SEER tabulates two population values: Asian alone
(scenario 1) and Asian alone or in combination (scenario 1-4 combined). Census population data
are tallies of the number of Asian responses rather than the number of Asian respondents. Gomez
et al. proposed a simple algorithm to calculate Asian-group specific population denominators by
averaging the two SEER values. However, their method cannot fully eliminate the inflation from
respondents reporting three or more specific Asian groups. In the present study, a bridging method
was applied to adjust for inflation caused by repeated counts from those reporting multiple Asian
races. With the growing multiracial population, further research is required to examine the impact
of multiracial Asians on cancer incidence and survival disparities.
3. Impact of nativity on cancer incidence and survival in Asian Americans
Studies have shown that cancer incidence and survival vary considerably between foreign-born
and US-born Asian Americans because health in immigrant populations tends to differ from that
of non-immigrants due to the maintenance of traditional cultural behaviors, the immigration
experience itself, and the characteristics of individuals who choose to migrate. Unfortunately,
neither information on birthplace nor length of stay in US is routinely collected by cancer registries.
Statistical approach has been developed by researchers in California to differentiate foreign-born
and US-born individuals using patient’s age at receiving a social security number. However, this
method has not been validated in any state other than California. Continued research is needed to
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more accurately assess the impact of nativity or length of stay in US of Asian Americans on their
cancer incidence and survival disparities.
4. Measure the awareness and usage of cancer screening and prevention in Asian Americans
Asian Americans are disproportionately affected by infection-related cancers. Most of these
cancers can be prevented by immunization or detected at early stage by screening. Assessing and
improving screening and prevention participation in Asian Americans is a key focus of research.
The National Health Interview Survey carries out annual assessments of self-reported adherence
to US Preventive Services Task Force screening recommendations. There is evidence for racial or
ethnic disparities in screening and prevention participation. However, these survey data aggregate
specific Asian subgroups into one single groups. Understanding and tackling ethnic disparities in
awareness and usage of cancer screening and prevention among Asian subgroups should be a key
issue for future research. Overall, there is an urgent need for research aimed at measuring the
different patterns of screening and vaccination behaviors among Asian Americans to inform the
development of interventions to address these inequalities.
In conclusion, continued research is needed to more accurately assess the cancer incidence and
survival disparities among the Asian American population. In order to realize the goal of
elimination of cancer health disparities, it remains essential that the future public health
professionals contributes to the current body of knowledge on this subject and encourages public
health practice and policy to become aligned with the research.
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